Veradigm Announces Leadership Updates
- CHICAGO--(BUSINESS WIRE)-- #healthIT--Veradigm Inc. (OTCMKTS: MDRX, the "Company”), a leading provider of healthcare data and technology solutions, today announced that, on June 7, 2024, Tom Langan, the Company's President and Chief Commercial Officer (CCO), will assume the role of interim Chief Executive Officer (CEO), reporting directly to the Executive Chairman and the Board. Mr. Langan has been a Company leader since 2018 and has more than 25 years of life sciences, payer and data & analytics exper.
- 05/28/2024
|
Veradigm to Explore Strategic Alternatives and Reaffirms 2024 Guidance
- CHICAGO--(BUSINESS WIRE)-- #healthIT--Veradigm Inc. (OTCMKTS: MDRX, the "Company”), a leading provider of healthcare data and technology solutions, today announced that it has initiated a process to explore strategic alternatives to maximize shareholder value. As part of the evaluation process, Veradigm will explore potential strategic alternatives that may include, but are not limited to, a sale, merger, strategic business combination or other transaction. The Company cannot assure that its exploration wi.
- 05/28/2024
|
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Veradigm Inc. (MDRX) on Behalf of Investors
- LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announces that it has commenced an investigation of potential claims against the board of directors of Veradigm Inc. (“Veradigm” or the “Company”) (NASDAQ: MDRX) concerning whether the board of directors breached its fiduciary duties to Veradigm shareholders. If you still hold Veradigm shares purchased before December 2020 and wish to discuss this matter with us, or have.
- 05/16/2024
|
Law Offices of Howard G. Smith Announces Investigation of Veradigm Inc. (MDRX) on Behalf of Investors
- BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that it has commenced an investigation of potential claims against the board of directors of Veradigm Inc. (“Veradigm” or the “Company”) (NASDAQ: MDRX) concerning whether the board of directors breached its fiduciary duties to Veradigm shareholders. On February 28, 2023, Veradigm disclosed that it “detected certain internal control failures related to revenue recognition that have occurred over the prior six quarters,” res.
- 05/15/2024
|
The Law Offices of Frank R. Cruz Announces Investigation of Veradigm Inc. (MDRX) on Behalf of Investors
- LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Veradigm Inc. (“Veradigm” or the “Company”) (NASDAQ: MDRX) concerning whether the board of directors breached its fiduciary duties to Veradigm shareholders. If you are a shareholder who suffered a loss, click here to participate. On February 28, 2023, Veradigm disclosed that it “detected certain internal control failures related to revenue recognition that have occurred over the prior six quarters,” res.
- 05/14/2024
|
MedEvolve Announces Strategic Marketing Relationship with Veradigm to Enhance Revenue Cycle Management Solutions for Healthcare Organizations
- LITTLE ROCK, Ark.--(BUSINESS WIRE)--MedEvolve, a leading provider of effective intelligence technology that provides, automation, transparency and accountability for the healthcare revenue cycle, is pleased to announce a strategic marketing relationship with Veradigm Inc. (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions. The agreement will make MedEvolve's Effective Intelligence (Ei) suite of workforce automation and intelligent analytics solutions, available dire.
- 04/30/2024
|
Veradigm Network Solution Practice Fusion EHR Receives Top Ambulatory Rankings
- CHICAGO--(BUSINESS WIRE)-- #healthIT--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today that Black Book, a healthcare-centric market research and public opinion research and consulting company, has ranked Practice Fusion first for Ambulatory EHR PM Family Practice and Ambulatory EHR PM Primary Care General Practice within its 2024 Top Client/User-Rated Electronic Health Records & Practice Management Solutions report. Practice Fusion, a Veradigm N.
- 04/09/2024
|
Veradigm and Vim to Improve Payer-Provider Collaboration
- CHICAGO--(BUSINESS WIRE)-- #healthIT--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions announced its strategic collaboration with Vim, a leading middleware platform for U.S. healthcare, to enhance point-of-care integration for EHR platforms and payers outside of the Veradigm EHR footprint. Along with the deployment of Veradigm Payer Insights, this collaboration marks a significant step in bridging the gap between payers and providers, ultimately benefiting patients.
- 04/03/2024
|
Update in Lawsuit for Investors who purchased shares of Veradigm Inc. (NASDAQ: MDRX) announced by the Shareholders Foundation
- SAN DIEGO , March 26, 2024 /PRNewswire/ -- The Shareholders Foundation, Inc. announced that a lawsuit is pending for certain investors in Veradigm Inc., f.k.a. Allscripts Healthcare Solutions, Inc. Investors, who purchased shares of Veradigm Inc. (NASDAQ: MDRX) prior to February 2021 and continue to hold any of those shares, have also certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
- 03/26/2024
|
Veradigm to Participate in KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
- CHICAGO--(BUSINESS WIRE)-- #healthIT--Veradigm Inc. (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions announced today that Dr. Yin Ho, Veradigm Interim Chief Executive Officer and board member, Lee Westerfield, Interim Chief Financial Officer, and Will Manidis Co-Founder of ScienceIO will participate in a fireside chat at the KeyBanc Capital Markets Life Science & MedTech Investor Forum on Tuesday, March 19th, 2024 at 12:00 PM EDT. The webcast will be available in the inve.
- 03/14/2024
|
Veradigm Announces Initial Financial Guidance for Fiscal 2024
- CHICAGO--(BUSINESS WIRE)-- #healthIT--Veradigm Inc. (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today it has reaffirmed the estimated, unaudited ranges for fiscal 2023 of GAAP Revenue, Adjusted EBITDA, and Non-GAAP diluted earnings per share that it provided on January 10, 2024, in the Company's Form 8-K filed on January 10, 2024, and initially reaffirmed on February 27, 2024. The company also introduced initial financial guidance for Fiscal 2024 as follows: R.
- 03/13/2024
|
Veradigm (MDRX) to Acquire AI Service Provider ScienceIO
- Veradigm (MDRX) is set to acquire ScienceIO to benefit its Provider, Payer and Life Sciences businesses, offering highly differentiated and advanced products to its customers.
- 03/01/2024
|
Veradigm Receives Expected Delisting Notice from Nasdaq
- CHICAGO--(BUSINESS WIRE)-- #healthIT--Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology products and solutions, announced today that, as expected, it received a notice from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Nasdaq Hearings Panel (the “Panel”) has determined to delist the common stock of the Company from Nasdaq (the “Decision”). The Decision indicates that the Company remains noncompliant with Nasdaq Listing Rule 5250(c)(1) and Nasdaq Listing Rule 56.
- 02/28/2024
|
Veradigm to Participate in TD Cowen Annual Health Care Conference
- CHICAGO--(BUSINESS WIRE)-- #healthIT--Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology products and solutions, today announced that Dr. Yin Ho, Veradigm interim Chief Executive Officer, and Lee Westerfield, interim Chief Financial Officer, will present at the TD Cowen Annual Health Care Conference on Monday, March 4, 2024, at 9:50 AM Eastern Time. About Veradigm® Veradigm is a healthcare technology company that drives value through its unique combination of platforms, data.
- 02/28/2024
|
Veradigm Provides Update on its Financial Restatement Process
- CHICAGO--(BUSINESS WIRE)-- #healthIT--Veradigm Inc. (NASDAQ: MDRX) (the “Company”), a leading provider of healthcare data and technology products and solutions, announced today that the Company does not expect to have filed its Annual Report on Form 10-K for the year ended December 31, 2022, or its Quarterly Reports on Form 10-Q for the quarters ended March 31, 2023, June 30, 2023 and September 30, 2023, by February 27, 2024, the deadline that The Nasdaq Stock Market LLC (“Nasdaq”) has given the Company to.
- 02/27/2024
|
Veradigm to Acquire ScienceIO
- CHICAGO--(BUSINESS WIRE)-- #healthIT--Veradigm Inc. (NASDAQ: MDRX) (the “Company”), a leading provider of healthcare data and technology products and solutions, today announced that it has signed a definitive agreement to acquire ScienceIO. The transaction has been unanimously approved by the Veradigm Board of Directors and is expected to close as promptly as practicable following the satisfaction of customary closing conditions. Founded in 2019, ScienceIO is a leading AI platform and foundation model prov.
- 02/27/2024
|
Veradigm to Highlight New EHR-Integrated Care Gap Alert Solution at ViVE 2024 Conference
- CHICAGO--(BUSINESS WIRE)-- #healthIT--Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology solutions, announced today that it will be highlighting the new Veradigm Payer Insights solution at the ViVE 2024 conference in Los Angeles, CA, Feb 25-28. Veradigm will be exhibiting at booth #1461. Gap closure is an important element in driving improved overall patient care and outcomes, but providers are not always aware of every gap that exists for their patients. If documentation of.
- 02/22/2024
|
Veradigm Reveals New Insights on the Prevalence of Cardiovascular Conditions in the U.S.
- CHICAGO--(BUSINESS WIRE)-- #healthIT--Which region of the U.S. has the highest rates of hypertension, coronary artery disease and heart failure? The South, according to this analysis on cardiovascular disease (CVD) from Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology solutions. Veradigm today released its inaugural Veradigm Insights Report: Cardiovascular Conditions in 2024, which examines de-identified real world data for 53 million unique cardiovascular patients. The re.
- 02/20/2024
|
Veradigm and American College of Cardiology Launch Influenza Vaccination Education Initiative to Improve Cardiovascular Health
- CHICAGO--(BUSINESS WIRE)-- #healthIT--Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology solutions announced today the launch of TRANSFORM VAX, an American College of Cardiology (ACC)-sponsored initiative aimed at improving cardiovascular health through increased influenza vaccination education. Influenza vaccination is associated with a lower risk for adverse cardiovascular events, with an overall 34% lower risk of major adverse cardiovascular events and a 45% lower risk am.
- 02/13/2024
|
Lawsuit Notice: Investors who lost money with Veradigm Inc. (NASDAQ: MDRX) shares should contact the Shareholders Foundation
- SAN DIEGO , Feb. 6, 2024 /PRNewswire/ -- The Shareholders Foundation, Inc. announced that a lawsuit is pending for certain investors in Veradigm Inc. (NASDAQ: MDRX) shares. Investors, who purchased shares of Veradigm Inc. (NASDAQ: MDRX) prior to February 2021 and continue to hold any of those shares, have also certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
- 02/06/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Veradigm Inc.- MDRX
- NEW YORK , Jan. 22, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Veradigm Inc. ("Veradigm" or the "Company") (NASDAQ: MDRX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
- 01/22/2024
|
FINAL DEADLINE TODAY: The Schall Law Firm Encourages Investors in Veradigm Inc. with Losses to Contact the Firm
- LOS ANGELES, CA / ACCESSWIRE / January 22, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Veradigm Inc. ("Veradigm" or "the Company") (NASDAQ: MDRX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 26, 2021 and June 13, 2023, inclusive (the "Class Period"), are encouraged to contact the firm before January 22, 2024.
- 01/22/2024
|
MDRX DEADLINE NOTICE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Veradigm Inc. f/k/a Allscripts Healthcare Solutions, Inc. Investors to Secure Counsel Before Important January 22 Deadline in Securities Class Action - MDRX
- NEW YORK , Jan. 21, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Veradigm Inc. f/k/a Allscripts Healthcare Solutions, Inc. (NASDAQ: MDRX) between February 26, 2021 and June 13, 2023, both dates inclusive (the "Class Period"), of the important January 22, 2024 lead plaintiff deadline. SO WHAT: If you purchased Veradigm common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
- 01/21/2024
|
Veradigm's (MDRX) Acquires Koha Health to Solidify Market Presence
- Veradigm's (MDRX) acquisition of Koha Health will likely enhance its ability to deliver efficient revenue cycle services by incorporating Musculoskeletal Medicine specialty subject matter expertise.
- 01/05/2024
|
Veradigm Leadership Team to Present at J.P. Morgan Healthcare Conference
- CHICAGO--(BUSINESS WIRE)-- #healthIT--Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology solutions, announced today that Dr. Shih-Yin Ho, Veradigm interim Chief Executive Officer and board member, and Lee Westerfield, interim Chief Financial Officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024 at 11:15 AM PST. Dr. Shih-Yin Ho and Lee Westerfield will provide an update on the business and its growth strategy that positions.
- 01/04/2024
|
Veradigm's (MDRX) New Offering to Enhance Patient Engagement
- Veradigm's (MDRX) latest solution is likely to offer its clients the right payment option to each individual patient through the right communication channel.
- 11/10/2023
|
Veradigm (MDRX)-FDB Vela to Enhance Pharmacy Connectivity
- Veradigm's (MDRX) latest progress with FDB Vela is likely to offer prescribers and patients greater choice and cost transparency.
- 10/09/2023
|
Veradigm (MDRX) Advances Tie-Up to Enhance Care Delivery
- Veradigm's (MDRX) new phase of strategic investment is likely to drive innovation and close the evidence gap in behavioral health.
- 10/04/2023
|
Veradigm's (MDRX) New Tie-Up to Boost Patients' Health Outcomes
- Veradigm's (MDRX) latest partnership is likely to promote value-based care initiatives for healthcare providers and the patients they serve.
- 09/29/2023
|
Veradigm: Some Promise Combined With Uncertainty
- Veradigm Inc. is a small-cap firm in the healthcare industry and its stock is trading near its 52-week low. The company was birthed out of Allscripts Healthcare Solutions, and the new entity provides data and analytics tools to healthcare providers. Veradigm's financial reports have been delayed, and it is likely to receive a delisting notice from NASDAQ.
- 09/22/2023
|
Here's Why You Should Retain Veradigm (MDRX) Stock for Now
- Veradigm (MDRX) continues to hold on to investors' interests owing to its strategic alliances.
- 05/15/2023
|
3 Service Stocks Poised to Beat Earnings Estimates in Q4
- Here we pick three business service stocks, namely PagSeguro Digital (PAGS), Veradigm (MDRX) and TuSimple (TSP), which are likely to pull off earnings surprises this time around.
- 02/22/2023
|
Will (MDRX) Beat Estimates Again in Its Next Earnings Report?
- (MDRX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 02/03/2023
|
MDRX or VERI: Which Is the Better Value Stock Right Now?
- MDRX vs. VERI: Which Stock Is the Better Value Option?
- 02/01/2023
|
Strength Seen in Veradigm (MDRX): Can Its 5.0% Jump Turn into More Strength?
- Veradigm (MDRX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
- 01/12/2023
|
Here's Why You Should Retain Veradigm (MDRX) Stock for Now
- Investors continue to be optimistic about Veradigm (MDRX) owing to its strategic alliances.
- 01/10/2023
|
Veradigm to Present at the 2023 J.P. Morgan Healthcare Conference
- CHICAGO--( BUSINESS WIRE )--Veradigm Inc. (Nasdaq:MDRX), formerly Allscripts Healthcare Solutions Inc., announced today that Rick Poulton, Veradigm Chief Executive Officer, will present at the 2023 J.P. Morgan Healthcare conference on Wednesday, January 11, 2023 at 3:45 PST.
- 01/06/2023
|
3 Reasons to Retain Allscripts (MDRX) Stock in Your Portfolio
- Investors continue to be optimistic about Allscripts (MDRX) owing to its strategic alliances.
- 12/07/2022
|
Allscripts Healthcare Solutions: The Picture Is Improving
- Allscripts Healthcare Solutions has done well to post sales and cash flow growth in recent quarters. The company still faces uncertainty and risks moving forward, but it's healthy and trading on the cheap.
- 11/22/2022
|
Allscripts Healthcare Solutions, Inc. (MDRX) Q3 2022 Earnings Call Transcript
- Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX ) Q3 2022 Earnings Conference Call November 3, 2022 4:30 PM ET Company Participants Jenny Gelinas - VP, IR Richard Poulton - CEO Thomas Langan - President and Chief Commercial Officer Leah Jones - CFO Conference Call Participants Stephanie Davis - SVB Securities Charles Rhyee - Cowen and Company Thomas Keller - RBC Capital Markets George Hill - Deutsche Bank Cynthia Motz - Goldman Sachs Eric Percher - Nephron Research Operator Greetings, and welcome to Allscripts' Third Quarter 2022 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.
- 11/05/2022
|
Allscripts (MDRX) Q3 Earnings Surpass Estimates, Margins Up
- Allscripts' (MDRX) robust Q3 results demonstrate strength in both segments.
- 11/04/2022
|
AllScripts Healthcare (MDRX) Q3 Earnings Top Estimates
- AllScripts (MDRX) delivered earnings and revenue surprises of 21.05% and 0.68%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
- 11/03/2022
|
3 Reasons to Retain Allscripts (MDRX) Stock in Your Portfolio
- Investors continue to be optimistic about Allscripts (MDRX) owing to its strategic alliances.
- 10/10/2022
|
MDRX vs. OMCL: Which Stock Is the Better Value Option?
- MDRX vs. OMCL: Which Stock Is the Better Value Option?
- 10/05/2022
|
MDRX vs. OMCL: Which Stock Should Value Investors Buy Now?
- MDRX vs. OMCL: Which Stock Is the Better Value Option?
- 08/09/2022
|
Allscripts Healthcare Solutions, Inc. (MDRX) CEO Rick Poulton on Q2 2022 Results - Earnings Call Transcript
- Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX ) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Jenny Gelinas - VP, IR Rick Poulton - CEO Tom Langan - President and Chief Commercial Officer Leah Jones - CFO Conference Call Participants Stephanie Davis - SVB Securities Cindy Motz - Goldman Sachs Charles Rhyee - Cowen Sean Dodge - RBC Capital Michael Cherny - Bank of America George Hill - Deutsche Bank Jeff Garro - Piper Stanley Dolph Warburton - Nephron Research Operator Ladies and gentlemen, good day, and thank you for joining us for this Allscripts Q2 2022 Earnings Conference Call. [Operator Instructions] Also a friendly reminder, today's session is being recorded.
- 08/07/2022
|
AllScripts Healthcare (MDRX) Tops Q2 Earnings and Revenue Estimates
- AllScripts (MDRX) delivered earnings and revenue surprises of 12.50% and 2.27%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
- 08/04/2022
|
Reasons to Retain Allscripts (MDRX) Stock in Your Portfolio
- Investors continue to be optimistic about Allscripts (MDRX) owing to its strategic alliances.
- 06/27/2022
|
Allscripts' (MDRX) Stock Falls 8.8% Post Q1 Earnings Miss
- Allscripts' (MDRX) robust Q1 results demonstrate strength in both segments.
- 05/10/2022
|
Allscripts Healthcare Solutions, Inc. (MDRX) CEO Paul Black on Q1 2021 Results - Earnings Call Transcript
- Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX ) Q1 2022 Earnings Conference Call May 5, 2022 4:30 PM ET Company Participants Jenny Gelinas - Vice President, Investor Relations Paul Black - Chief Executive Officer Rick Poulton - President & Chief Financial Officer Conference Call Participants Sean Dodge - RBC Capital Markets Jeff Garro - Piper Sandler Stephanie Davis - SVB Securities Allen Lutz - Bank of America Operator Greetings and welcome to the Allscripts First Quarter 2022 Earnings Conference Call. At this time all participants are in a listen-only mode.
- 05/08/2022
|
AllScripts Healthcare (MDRX) Q1 Earnings and Revenues Lag Estimates
- AllScripts (MDRX) delivered earnings and revenue surprises of -35% and 61.72%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
- 05/05/2022
|
Here's Why You Should Retain Allscripts (MDRX) Stock For Now
- Investors continue to be optimistic about Allscripts Healthcare Solutions (MDRX) owing to its strategic alliances.
- 04/22/2022
|
EDOC: Healthcare Technology Needs Time To Reach Its Potential
- EDOC: Healthcare Technology Needs Time To Reach Its Potential
- 03/24/2022
|
Reasons to Add Allscripts (MDRX) Stock to Your Portfolio
- Investors continue to be optimistic about Allscripts Healthcare Solutions (MDRX) owing to its strategic alliances.
- 03/21/2022
|
Surging Earnings Estimates Signal Upside for AllScripts (MDRX) Stock
- AllScripts (MDRX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
- 03/17/2022
|
Medical IT Providers Marching to Their Own Beat
- Medical IT Providers Marching to Their Own Beat
- 03/10/2022
|
Allscripts (MDRX) Unveils Newly Rebranded App Expo Site
- Allscripts' (MDRX) rebranded App Expo site to offer developers an opportunity to present their certified solutions online.
- 03/10/2022
|
Allscripts (MDRX) Up 4.5% Since Q4 Earnings: What's Driving It?
- Allscripts' (MDRX) stock rallies on better-than-expected fourth-quarter performance and recent alliances.
- 03/09/2022
|
Allscripts (MDRX) Inks Divestment Deal to Focus on Core Wing
- Constellation Software will purchase the net assets of Allscripts' (MDRX) Hospitals and Large Physician Practices business segment via its wholly-owned subsidiary.
- 03/09/2022
|
4 Stocks in Spotlight With AI Making Inroads in MedTech
- MedTech stocks like Medtronic (MDT), Stryker (SYK), Allscripts Healthcare Solutions (MDRX) and Syneos Health (SYNH) are evolving rapidly in the field of AI-driven technologies.
- 03/07/2022
|
Allscripts Healthcare Solutions, Inc.'s (MDRX) CEO Paul Black on Q4 2021 Results - Earnings Call Transcript
- Allscripts Healthcare Solutions, Inc.'s (MDRX) CEO Paul Black on Q4 2021 Results - Earnings Call Transcript
- 02/25/2022
|
5 Top Stocks Likely to Beat Earnings Estimates
- These top-ranked stocks are likely to beat on bottom line in their next releases.
- 02/10/2022
|
Surging Earnings Estimates Signal Upside for AllScripts (MDRX) Stock
- AllScripts (MDRX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
- 01/27/2022
|
Allscripts (MDRX) Reports Solid Preliminary Q4 Revenues
- Allscripts' (MDRX) revenue growth in the fourth quarter is likely to have been boosted by solid segmental performances.
- 01/26/2022
|
Is AllScripts Healthcare (MDRX) Outperforming Other Medical Stocks This Year?
- Here is how AllScripts Healthcare (MDRX) and Pharvaris N.V. (PHVS) have performed compared to their sector so far this year.
- 01/26/2022
|
Why Allscripts Stock Blasted 16% Higher Today
- If the company's latest set of preliminary results is any indication, it had a far better than expected Q4 and full-year 2021.
- 01/25/2022
|
Allscripts Stock (MDRX): Why The Price Substantially Went Up Today
- The stock price of Allscripts Healthcare Solutions Inc (NASDAQ: MDRX) increased by over 14% during intraday trading today. This is why it happened.
- 01/25/2022
|
Allscripts Expects Q4 Interim Sales Beat Consensus; Approves $250M Buyback
- Allscripts Healthcare Solutions Inc (NASDAQ: MDRX) expects Q4 revenue of $390 million - $395 million, better than the consensus of $$386.75 million. For FY21, the Company expects GAAP operating income of $70 million - $75 million and adjusted EBITDA of $295 million - $300 million, an increase from the prior outlook of $275 million - $285 million.
- 01/25/2022
|
Here's Why You Should Retain Allscripts (MDRX) Stock For Now
- Investors continue to be optimistic about Allscripts (MDRX) owing to its strategic alliances and various innovation milestones.
- 12/02/2021
|
Allscripts' (MDRX) Services Leveraged by Next Level Urgent Care
- Allscripts' (MDRX) Touchworks platform and Microsoft Azure hosting & services will be implemented across all Next Level Urgent Care's sites in Houston.
- 11/23/2021
|
Allscripts Healthcare Solutions, Inc. (MDRX) CEO Paul Black on Q3 2021 Results - Earnings Call Transcript
- Allscripts Healthcare Solutions, Inc. (MDRX) CEO Paul Black on Q3 2021 Results - Earnings Call Transcript
- 11/07/2021
|
Allscripts' (MDRX) Q3 Earnings Beat Estimates, Margins Up
- Allscripts' (MDRX) robust Q3 results demonstrate strength in both segments.
- 11/05/2021
|
AllScripts Healthcare (MDRX) Q3 Earnings Surpass Estimates
- AllScripts (MDRX) delivered earnings and revenue surprises of 50.00% and -1.91%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
- 11/04/2021
|
Analysts Estimate AllScripts Healthcare (MDRX) to Report a Decline in Earnings: What to Look Out for
- AllScripts (MDRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 10/28/2021
|
Allscripts' (MDRX) New AI-Based Offering to Improve Patient Care
- Allscripts' (MDRX) latest AI-based scheduling application is expected to provide improved patient care as well as increase operational efficiencies of the healthcare system.
- 10/18/2021
|
Allscripts Launches Guided Scheduling, Leveraging Artificial Intelligence to Improve Patient Care and Increase Healthcare Operational Efficiencies
- CHICAGO--(BUSINESS WIRE)--Allscripts (NASDAQ MDRX) Guided Scheduling, launching in Allscripts Practice Management, is an artificial intelligence scheduling application that uses real-time provider, practice, and industry data to optimize providers' days. The system looks at key clinical and operational metrics, allowing users to appropriately schedule each patient visit. Allscripts Guided Scheduling can result in the increased speed of high-need patients receiving care, the improved utilization
- 10/14/2021
|
SEMCAP's Seminal Healthcare Expands its Investment Team, including Victor Kats as a Managing Partner
- PHILADELPHIA--(BUSINESS WIRE)--Seminal Capital Holdings, LLC ("SEMCAP") announces the appointments of Victor Kats (Managing Partner), Mark Miller (Managing Director) and Lindsey Watson (Managing Director – Portfolio Impact) to its Seminal Healthcare team. These latest additions further differentiate Seminal Healthcare's deep healthcare investing experience and team, which includes an active network of leading Senior Operating Advisors who represent some of the most influential leaders in health
- 10/13/2021
|
Allscripts (MDRX), CareMetx Tie Up for Better Patient Care
- Allscripts' (MDRX) Veradigm enters collaboration with CareMetx to streamline specialty medication management for medical clinics and practices across the nation.
- 10/13/2021
|
Veradigm Partners with CareMetx, LLC to Optimize End-to-End Specialty Medication Access and Services Streamlining Patient Care
- CHICAGO--(BUSINESS WIRE)--Veradigm®, a leading provider of healthcare data and technology solutions and a business unit of Allscripts Healthcare Solutions (NASDAQ: MDRX), and CareMetx, a leading technology-enabled hub services company focused on improving patient access to specialty medications, announced today a new agreement for CareMetx to integrate its solutions and services directly into the Veradigm AccelRx® specialty medication platform. The agreement will make Veradigm's AccelRx automat
- 10/05/2021
|
Eastern Health Selects Allscripts as One of Its Partners to Further Healthcare Innovation
- CHICAGO--(BUSINESS WIRE)--Allscripts (NASDAQ: MDRX) is pleased to have been selected as one of Eastern Health's innovation partners. As a result, Allscripts and Eastern Health have partnered to advance health-care services and programs while maximizing health system efficiencies and general economic development in Newfoundland and Labrador. The goal of this partnership is to improve health care and better serve its patients and their family members. Eastern Health is the largest health authorit
- 09/15/2021
|
Here's Why You Should Retain Allscripts (MDRX) Stock For Now
- Investors continue to be optimistic about Allscripts (MDRX) owing to its strategic alliances and solid prospects of the Sunrise EHR platform.
- 09/13/2021
|
Allscripts hosts Developer Challenge: Advancing Health Equity Using Social Determinants of Health
- CHICAGO--(BUSINESS WIRE)--Allscripts (NASDAQ: MDRX) recently hosted its Advancing Health Equity Using Social Determinants of Health Developer Challenge in an effort to elevate solutions that use technology to share relevant social determinants of health patient information with care providers. Access to patients' social determinants of health (SDOH) information is crucial in advancing health equity across patient populations—especially at a time when equitable access to healthcare is more impor
- 08/18/2021
|
Allscripts' (MDRX) Shares Up Following Q2 Earnings Beat
- Allscripts' (MDRX) robust Q2 results demonstrate its strength in Client services segment.
- 08/09/2021
|
Allscripts Healthcare Solutions, Inc. (MDRX) CEO Paul Black on Q2 2021 Results - Earnings Call Transcript
- Allscripts Healthcare Solutions, Inc. (MDRX) CEO Paul Black on Q2 2021 Results - Earnings Call Transcript
- 08/08/2021
|
Allscripts to Release Second-Quarter 2021 Financial Results August 5
- CHICAGO--(BUSINESS WIRE)--Allscripts Healthcare Solutions, Inc. (Nasdaq:MDRX) will report its financial results for the three months ended June 30, 2021 after the close of stock market hours on Thursday, August 5, 2021. Allscripts management plans to host a conference call and webcast to discuss the company's earnings at 4:30 p.m. Eastern Time that same day. Second-Quarter 2021 Financial Results Call Details The Allscripts earnings announcement will be distributed immediately after the close of
- 07/22/2021
|
MedTech Thrives on Healthcare IT in 2021: 4 Stocks to Focus on
- Health IT stocks like HealthEquity (HQY), Veeva Systems (VEEV), Tabula Rasa (TRHC) and Allscripts (MDRX) are expected to continue their run over the next few months.
- 07/16/2021
|
Invest in 3 Top-Performing Sectors for Gains in 2H21
- Amid the current market incongruity, investors should definitely invest in the best- performing sectors for secure gains ahead.
- 07/12/2021
|
Here's Why You Should Retain Allscripts (MDRX) Stock for Now
- Investors continue to be optimistic about Allscripts (MDRX) owing to its strategic alliances and solid prospects of the Sunrise EHR platform.
- 07/06/2021
|
Allscripts' (MDRX) Unit Inks Deal to Boost Clinical Research
- Allscripts' (MDRX) unit, Veradigm, enters into a strategic partnership with PRA Health (PRAH) to expand patients' access to clinical research.
- 06/25/2021
|
Digital Health Momentum is Here to Stay: 3 MedTech Stocks in Focus
- Here we look at three stocks, MDRX, CERN and RMD, that investors can keep a watch on the back of their robust digital health prospects.
- 06/24/2021
|
Leigh Burchell, Allscripts Vice President, Policy and Government Affairs, receives HIMSS21 Most Influential Women in Health IT Award
- CHICAGO--(BUSINESS WIRE)--HIMSS has announced Leigh Burchell, Allscripts Vice President, Policy and Government Affairs, as a recipient of the HIMSS21 Most Influential Women in Health IT Award. The Most Influential Women in Health IT Awards recognize and celebrate influential female leaders who harness the power of information and technology to transform health and healthcare. The winners are unique among power lists and award programs, and they are inclusive of all women of influence, no matter
- 06/14/2021
|
3 Stocks With Telehealth Offerings for Post-Pandemic Gains
- Stocks like CVS Health (CVS), Walgreens Boots Alliance (WBA) and Allscripts (MDRX) are expected to continue to grow post-pandemic on a series of remote health care product and service launches.
- 06/14/2021
|
Final Trades: Allscripts, Kinder Morgan, Merck & more
- The "Halftime Report" traders give their top picks to watch for the second half.
- 06/11/2021
|
Here's Why You Should Retain Allscripts (MDRX) Stock for Now
- Investors continue to be optimistic about Allscripts (MDRX) owing to its strategic alliances and solid prospects of the Sunrise EHR platform.
- 06/02/2021
|
Allscripts Announces New Share Repurchase Program
- CHICAGO--(BUSINESS WIRE)--Allscripts Healthcare Solutions announced today that its Board of Directors has approved a new share repurchase program under which Allscripts may purchase up to $350 million of its common stock. The new share repurchase program does not have a termination date. The new share repurchase program replaces the previously existing share repurchase program, which authorized Allscripts to repurchase $300 million of its common stock through December 31, 2021. Allscripts repur
- 05/26/2021
|
Veradigm Announces Collaboration With Lash Group to Streamline Patient Care
- CHICAGO--(BUSINESS WIRE)--Veradigm®, a leading provider of data and technology solutions and a business unit of Allscripts Healthcare Solutions (NASDAQ: MDRX), today announced an agreement with Lash Group, a patient support services business, and a part of AmerisourceBergen. This relationship will enable specialty medications, supported by Lash Group, to be available for management within the Veradigm AccelRx™ platform, which streamlines the specialty enrollment process for users of Veradigm, A
- 05/25/2021
|
US Orthopedic Alliance Selects 2bPrecise to Accelerate Precision Medicine Program
- RALEIGH, N.C. & LAKE FOREST, Calif.--(BUSINESS WIRE)-- #digitalhealth--US Orthopedic Alliance (USOA) selected 2bPrecise to provide its precision medicine platform to USOA's network of more than 100 orthopedic surgeons.
- 05/24/2021
|
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Allscripts Healthcare Solutions, Inc.- MDRX
- New York, New York--(Newsfile Corp. - May 14, 2021) - Levi & Korsinsky announces it has commenced an investigation of Allscripts Healthcare Solutions, Inc. (NASDAQ: MDRX) concerning possible breaches of fiduciary duty. To obtain additional information, go to:https://www.zlk.com/compensation2/allscripts-healthcare-solutions-inc-information-request-formor contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500. There is no cost or obligation to you.
- 05/14/2021
|
Blessing Health System Strengthens Its Allscripts Strategic Partnership
- CHICAGO--(BUSINESS WIRE)--Allscripts (NASDAQ: MDRX) is thrilled to publicize that client Blessing Health System, a not-for-profit healthcare organization located in Quincy, IL, has substantially expanded its Allscripts partnership to three facilities—Blessing Health Keokuk, Hannibal Clinic, and partner provider Scotland County Hospital. The health system has also acquired Allscripts Managed Services and has extended its agreement through 2028. “Allscripts has been our trusted partner for more t
- 05/13/2021
|
Allscripts to Present at the 2021 Bank of America Health Care Conference
- CHICAGO--(BUSINESS WIRE)--Allscripts (NASDAQ: MDRX) today announced that certain members of its management team will present at the 2021 Bank of America Health Care conference on Tuesday, May 11 at 11:00 am ET. The live webcast and replay can be accessed at http://investor.allscripts.com under the "Events and Presentations" section of the website. About Allscripts Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operationa
- 05/10/2021
|
Allscripts (MDRX) Inches Up 0.3% on Earnings Beat in Q1
- Allscripts (MDRX) witnesses a year- over- year surge in earnings during Q1.
- 05/05/2021
|
Allscripts Announces ADP Empower to Help Amplify Diverse Voices in the Healthcare Technology Industry
- CHICAGO--(BUSINESS WIRE)--Allscripts (NASDAQ: MDRX) today announced its team that leads the Allscripts Developer Program (ADP) has launched ADP Empower, a new program designed to amplify diverse voices in the healthcare technology industry and offer valuable resources to underrepresented entrepreneurs to grow their businesses and accelerate innovation. The Allscripts Developer Program helps build a culture of innovation by reducing barriers and risk associated with installing and using innovati
- 05/05/2021
|
Allscripts Healthcare Solutions, Inc. (MDRX) CEO Paul Black on Q1 2021 Results - Earnings Call Transcript
- Allscripts Healthcare Solutions, Inc. (MDRX) CEO Paul Black on Q1 2021 Results - Earnings Call Transcript
- 04/29/2021
|
Allscripts Healthcare: Q1 Earnings Insights
- Shares of Allscripts Healthcare (NASDAQ:MDRX) rose in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 111.11% year over year to $0.19, which beat the estimate of $0.15.
- 04/29/2021
|
Allscripts to Release First-Quarter 2021 Financial Results April 29
- CHICAGO--(BUSINESS WIRE)--Allscripts Healthcare Solutions, Inc. (Nasdaq:MDRX) will report its financial results for the three months ended March 31, 2021 after the close of stock market hours on Thursday, April 29, 2021. Allscripts management plans to host a conference call and webcast to discuss the company's earnings at 4:30 p.m. Eastern Time that same day. First-Quarter 2021 Financial Results Call Details The Allscripts earnings announcement will be distributed immediately after the close of
- 04/19/2021
|
Allscripts Healthcare Solutions: A Mini Salesforce In Healthcare IT Making All The Right Moves
- Allscripts looks like a relatively solid investment bet in the healthcare IT sector that has grown its share price by 140% in the past 12 months. Share price growth has stagnated in recent months perhaps owing to a modest revenue forecast of $1.5bn in FY20 - the same as in FY20.
- 04/19/2021
|
Allscripts' (MDRX) Solution Gets Selected by Revo Health
- Allscripts' (MDRX) Practice Management solution to improve financial and operational performance of all i-Health clinics of Revo Health.
- 04/07/2021
|
Revo Health selects Allscripts® Practice Management
- CHICAGO--(BUSINESS WIRE)--Allscripts Healthcare, LLC (Nasdaq:MDRX) announced today that it has partnered with Revo Health, LLC (Revo) to provide Allscripts Practice Management and Payerpath, helping to drive financial and operational performance to all of its Infinite Health Collaborative (i-Health) clinics. i-Health currently uses Allscripts TouchWorks® electronic health record and the Allscripts patient engagement solution, FollowMyHealth®. Revo is a management services organization that prov
- 04/05/2021
|
Allscripts' (MDRX) Sunrise Platform Picked by Mercy Iowa City
- Allscripts' (MDRX) Sunrise platform gets selected by Mercy Iowa City, thereby enabling the former to help in delivering better patient outcomes and accelerating the future of healthcare.
- 03/29/2021
|
AllScripts (MDRX) Down 2.8% Since Last Earnings Report: Can It Rebound?
- AllScripts (MDRX) reported earnings 30 days ago. What's next for the stock?
- 03/27/2021
|
Here's Why You Should Retain Allscripts (MDRX) Stock for Now
- Investor confidence is high on Allscripts (MDRX) stock, courtesy of solid prospects.
- 03/15/2021
|
Allscripts rated #1 in Black Book™ Research's 2021 Community Health Systems Vendors Report
- CHICAGO--(BUSINESS WIRE)---- $MDRX #HealthIT--Allscripts (NASDAQ: MDRX) has been recognized as the top-rated electronic health record vendor for community hospitals according to new survey results from Black Book Research. This is the fifth consecutive year Allscripts has earned the top rating in this annual survey. The survey features responses collected from more than 1,800 community hospitals and focuses on 18 key performance indicators. Approximately 50% of the responses came from nurses, physicians, and other
- 03/11/2021
|
Allscripts (MDRX) Q4 Earnings and Revenues Beat Estimates
- Allscripts (MRDX) witnessed expansion in gross margin, driven by better-than-expected software revenues and consistent decline in operating expenses.
- 02/26/2021
|
Allscripts Healthcare Solutions, Inc. (MDRX) CEO Paul Black on Q4 2020 Results - Earnings Call Transcript
- Allscripts Healthcare Solutions, Inc. (MDRX) CEO Paul Black on Q4 2020 Results - Earnings Call Transcript
- 02/25/2021
|
AllScripts Healthcare (MDRX) Surpasses Q4 Earnings and Revenue Estimates
- AllScripts (MDRX) delivered earnings and revenue surprises of 31.82% and 1.86%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
- 02/25/2021
|
Can AllScripts (MDRX) Keep the Earnings Surprise Streak Alive?
- AllScripts (MDRX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 02/23/2021
|
President of Israel Reuven Rivlin Visits Allscripts Office in Beer Sheva
- CHICAGO--(BUSINESS WIRE)-- #healthIT--Allscripts Healthcare Solutions, Inc. (Nasdaq:MDRX) recently hosted Mr. Reuven Rivlin, President of Israel, and the Mayor of Beer Sheva, Mr. Ruvik Danilovich, at its office in Beer Sheva, Israel. The two, along with Allscripts leadership, discussed how Allscripts interoperability solution, dbMotion, connects all clinical venues in Israel, as well as the impact the solution has had during the pandemic. With 30 health organizations across the country connected to a natio
- 02/18/2021
|
Allscripts to Release Fourth-Quarter and Full Year 2020 Financial Results February 25
- CHICAGO--(BUSINESS WIRE)-- #healthIT--Allscripts Healthcare Solutions, Inc. (Nasdaq:MDRX) will report its financial results for the three months and full year ended December 31, 2020 after the close of stock market hours on Thursday, February 25, 2021. Allscripts management plans to host a conference call and webcast to discuss the company's earnings at 4:30 p.m. Eastern Time that same day. Fourth-Quarter and Full Year 2020 Financial Results Call Details The Allscripts earnings announcement will be distrib
- 02/12/2021
|
Allscripts Healthcare Solutions: Pricey But On The Right Track
- Allscripts Healthcare Solutions: Pricey But On The Right Track
- 02/11/2021
|
ConnectiveRx Announces Exclusive Partnership with Veradigm to Deliver High-Impact Point-of-Care Communications
- WHIPPANY, N.J.--(BUSINESS WIRE)--ConnectiveRx, a leading provider of technology-enabled patient support and access solutions for specialty and branded medications, announced today that it has entered into a long-term strategic partnership with Veradigm, an Allscripts (NASDAQ: MDRX) business unit, to deliver a broad portfolio of point of care prescription-related messages to patients. The three-year agreement takes effect March 1, 2021. Based on this partnership and the establishment of a new pr
- 02/01/2021
|
3 Top Medical Info Systems Stocks to Beat COVID-19 Resurgence Crisis
- 3 Top Medical Info Systems Stocks to Beat COVID-19 Resurgence Crisis
- 01/28/2021
|
Allscripts (MDRX) Extends Tie-Up With US Orthopedic Alliance
- Allscripts (MDRX) extends strategic partnership with US Orthopedic Alliance to form a more scalable orhopedic services technology platform.
- 01/27/2021
|
Allscripts Collaborates With Microsoft, MATTER and ARC Innovation Center at Sheba Medical Center to Discover New Innovations
- CHICAGO--(BUSINESS WIRE)-- #healthIT--Allscripts Healthcare Solutions (NASDAQ: MDRX), MATTER, Microsoft and ARC Innovation Center at Sheba Medical Center hosted a challenge in December for health IT developers focused on reimagining care delivery. 2020 marked 200 years since the trailblazing social reformer and nurse Florence Nightingale was born, and in honor of the mark she left on healthcare, the World Health Organization named 2020 the International Year of the Nurse and Midwife. With her legacy in min
- 01/27/2021
|
Allscripts and US Orthopedic Alliance Expand Strategic Partnership, Ushering in ‘The Gold Standard' For Orthopedic Technology Platforms
- CHICAGO--(BUSINESS WIRE)-- #healthIT--Allscripts Healthcare Solutions (NASDAQ: MDRX) today announced a strategic technology partnership with US Orthopedic Alliance (USOA), an orthopedic management services provider based in Southern California, to support USOA's growth and pursue additional relationships with leading orthopedic providers nationwide. The partnership will bring to market best-of-breed infrastructure designed to help orthopedic practices scale with agility, improve EHR implementation timeline
- 01/26/2021
|
3 Biggest MedTech Trends to Watch in 2021 for Better Returns
- Following are the three MedTech trends, which showed a steady momentum through the pandemic year and are likely to sustain even after the economic mayhem subsides.
- 01/20/2021
|
Allscripts to Present at the 2021 J.P. Morgan Virtual Healthcare Conference
- CHICAGO--(BUSINESS WIRE)-- #healthIT--Allscripts (NASDAQ: MDRX) today announced that certain members of its management team will present at the 2021 J.P. Morgan Virtual Healthcare conference on Tuesday, January 12 at 2:50 pm ET. The live webcast and replay can be accessed at http://investor.allscripts.com under the "Events and Presentations" section of the website. About Allscripts Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and oper
- 01/08/2021
|
Allscripts (MDRX) Completes Sale of CarePort Health Business
- Allscripts' (MDRX) agreement with WellSky empowers providers with efficient care transitions and better patient health outcomes.
- 01/05/2021
|
Allscripts Closes Previously Announced Sale of CarePort Health Business
- CHICAGO--(BUSINESS WIRE)-- #healthIT--On December 31, 2020, Allscripts (NASDAQ: MDRX) closed the previously announced sale of its CarePort Health business to WellSky® Corporation for $1.35 billion. CarePort solutions assist hundreds of hospitals and thousands of post-acute care providers to efficiently coordinate and transition patients through different settings of care. About Allscripts Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial a
- 01/04/2021
|
Here's Why You Should Retain Allscripts (MDRX) Stock for Now
- Investor confidence is high on Allscripts (MDRX) stock on the back of its solid prospects.
- 12/23/2020
|
Allscripts Sunrise™ 20.0 Now Generally Available
- CHICAGO--(BUSINESS WIRE)-- #healthIT--Allscripts Healthcare Solutions (NASDAQ: MDRX) announced that Sunrise 20.0 is now generally available. Sunrise is a comprehensive platform of health that connects all aspects of care, including acute, ambulatory, surgical, pharmacy, radiology and laboratory services, and also features an integrated revenue cycle and patient administration system. Sunrise is a clinician-friendly, evidence-based single platform with integrated analytics that helps deliver better health o
- 12/16/2020
|
Allscripts stock rallies after $200 million accelerated stock buyback plan
- Shares of Allscripts Healthcare Solutions Inc. rose 2.3% in premarket trading Tuesday, after the health care information technology company set a $200 million accelerated stock repurchase (ASR) plan. That represents about 9.3% of the company's market capitalization of $2.16 billion, based on Monday's stock closing price of $13.68.
- 12/01/2020
|
Allscripts Announces $200 Million Accelerated Share Repurchase
- CHICAGO--(BUSINESS WIRE)-- #healthIT--Allscripts Healthcare Solutions (NASDAQ: MDRX) today announced that as part of its capital return program it has entered into accelerated share repurchase (“ASR”) transactions with each of JPMorgan Chase Bank, National Association and Wells Fargo Bank, National Association to repurchase an aggregate of $200 million of its common stock. “The accelerated share repurchase demonstrates our commitment to delivering near-term value to our shareholders, our strong liquidity p
- 12/01/2020
|
Allscripts partners with Nurse Heroes to support and honor frontline workers
- CHICAGO--(BUSINESS WIRE)-- #healthIT--Allscripts Healthcare Solutions (NASDAQ: MDRX) announced today that the Company is an ambassador for Nurse Heroes, a new initiative created to recognize and honor nurses, while also helping educate and empower them for their careers. Through this partnership, Allscripts supports Nurse Heroes in providing scholarships for nurses to either begin nursing school or complete higher-ed certification programs for medical career advancement. Allscripts joins motivated philanth
- 11/23/2020
|
Veradigm and HealthVerity Expand Existing Partnership with Novel Linked Real-World Data Packages
- CHICAGO--(BUSINESS WIRE)-- #healthIT--Veradigm®, an Allscripts (NASDAQ: MDRX) business unit leading the industry with real-world data and analytic solutions, and HealthVerity, the leader in privacy-protected data exchange, today announced that they have entered into a strategic partnership that extends the companies' current relationship. The initial focus is on the development of innovative HIPAA-compliant data products created by linking real-world data from a variety of leading sources. In addition to g
- 11/17/2020
|
7 Healthcare Stocks That Can Survive Massive Reform
- These seven healthcare stocks may represent robust long-term investments no matter how reforms in the sector may develop post-election. The post 7 Healthcare Stocks That Can Survive Massive Reform appeared first on InvestorPlace.
- 11/02/2020
|
Allscripts Healthcare Solutions, Inc. (MDRX) CEO Paul Black on Q3 2020 Results - Earnings Call Transcript
- Allscripts Healthcare Solutions, Inc. (MDRX) CEO Paul Black on Q3 2020 Results - Earnings Call Transcript
- 10/29/2020
|
Global Home Healthcare Software Markets, 2020-2025: Hospice Software Solutions is Expected to be the Fastest Growing Segment - ResearchAndMarkets.com
|
Netsmart Announces a New Era of Healthcare Technology That Transcends Care Settings
- Netsmart announced a new era of technology adoption at the thirteenth annual CONNECTIONS2020 three-day virtual user group conference.
- 10/08/2020
|
Allscripts and Sheba Medical Center Launch Partnership to Further Healthcare Innovation
- Allscripts (NASDAQ: MDRX) and Israel’s Sheba Medical Center have formed a partnership to accelerate the pace of artificial intelligence technologies and to improve patient care through the hospitals’ ARC Innovation Center. ARC, which is an acronym for accelerate, redesign, and collaborate, is the innovation arm of Sheba Medical Center which has a vision to transform healthcare by 2030.
- 08/19/2020
|
Did Hedge Funds Make The Right Call On Allscripts Healthcare Solutions Inc (MDRX) ?
- Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and successful investors' positions as of the end of the first quarter. You can find articles about an individual hedge fund's trades on numerous financial […]
- 08/12/2020
|
Calculating The Intrinsic Value Of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX)
- Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Allscripts Healthcare...
- 08/11/2020
|
Here's What We Think About Allscripts Healthcare Solutions' (NASDAQ:MDRX) CEO Pay
- Paul Black became the CEO of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) in 2012, and we think it's a good...
- 08/11/2020
|
Healthcare Descriptive Analysis Industry 2020-2025: Financial Data Analytics Expected to Dominate Over the Forecast Period - ResearchAndMarkets.com
|
Allscripts Announces Appointment of New Director to Board
- Carol Zierhoffer has been named to the Board of Directors of Allscripts (NASDAQ: MDRX) Healthcare Solutions, Inc. A former executive at engineering and construction company Bechtel Corporation, Zierhoffer has more than 30 years of experience in information technology. She will serve as a member of the Audit Committee of the Board.
- 08/10/2020
|
Allscripts Announces Appointment of New Director to Board
- Carol Zierhoffer has been named to the Board of Directors of Allscripts (NASDAQ: MDRX) Healthcare Solutions, Inc. A former executive at engineering an
- 08/10/2020
|
Allscripts (MDRX) Q2 Earnings and Revenues Beat Estimates
- Allscripts (MDRX) witnessed decline in core Client Services and Software delivery unit revenues during Q2.
- 08/03/2020
|
Allscripts Cloud-Based EHR Solution to Support MicroHealth, LLC for Use Within the United States Department of State | | IT Business Net
- CHICAGO--(BUSINESS WIRE)--#healthIT--Allscripts (NASDAQ: MDRX) today announced that it will serve as a subcontractor to the prime contractor, MicroHealth, LLC, a health information technology firm, as
- 08/03/2020
|
Allscripts Cloud-Based EHR Solution to Support MicroHealth, LLC for Use Within the United States Department of State
- Allscripts (NASDAQ: MDRX) today announced that it will serve as a subcontractor to the prime contractor, MicroHealth, LLC, a health information technology firm, as they work to migrate the U.S. Department of State medical health units to a cloud-based solution for its global electronic health records.
- 08/03/2020
|
Allscripts Cloud-Based EHR Solution to Support MicroHealth, LLC for Use Within the United States Department of State
- Allscripts (NASDAQ: MDRX) today announced that it will serve as a subcontractor to the prime contractor, MicroHealth, LLC, a health information techno
- 08/03/2020
|
Allscripts Healthcare Solutions, Inc. (MDRX) CEO Paul Black on Q2 2020 Results - Earnings Call Transcript
- Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Q2 2020 Earnings Conference Call July 30, 2020 16:30 ET Company Participants Stephen Shulstein - Vice President, Investor Relations Paul Black - Chief Executive Officer Rick Poulton - President and Chief Financial Officer Conference Call Participants Charles Rhyee - Cowen & Company Robert Jones - Goldman Sachs Sean Dodge - RBC Capital Markets George Hill - Deutsche Bank Eric Percher - Nephron Research Stephanie Davis - SVB David Windley - Jefferies Michael Cherny - Bank of America Matthew Gillmor - Baird Richard Close - Canaccord Genuity Raymond Xu - Morgan Stanley Presentation Operator Hello and welcome to the Allscripts’ Second Quarter 2020 Earnings Conference Call.
- 08/02/2020
|
$431.37 Million in Sales Expected for Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) This Quarter
- Analysts expect that Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) will announce $431.37 million in sales for the current fiscal quarter, according to Zacks. Eight analysts have provided estimates for Allscripts Healthcare Solutions’ earnings. The highest sales estimate is $454.70 million and the lowest is $400.10 million. Allscripts Healthcare Solutions reported sales of $444.60 million in the […]
- 08/02/2020
|
Allscripts Healthcare Solutions, Inc. 2020 Q2 - Results - Earnings Call Presentation
- The following slide deck was published by Allscripts Healthcare Solutions, Inc. in conjunction with their 2020 Q2 earnings call..
- 07/31/2020
|
Allscripts to sell decision support subsidiary EPSi for $365M
- Strata Decision Technology, a Chicago-based company that makes decision support software, will acquire Allscripts subsidiary EPSi for $365 million.
- 07/31/2020
|
AllScripts Healthcare (MDRX) Tops Q2 Earnings and Revenue Estimates
- AllScripts (MDRX) delivered earnings and revenue surprises of 50.00% and 1.60%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
- 07/30/2020
|
Strata Decision Technology to Acquire EPSi From Allscripts
- Strata Decision Technology (Strata), a pioneer and leader in the development of cloud-based financial planning, analytics and performance tools for healthcare, today announced that it has reached a definitive agreement to acquire EPSi from Allscripts (NASDAQ: MDRX) for $365 million. EPSi is a leading provider of financial decision support and planning tools for hospitals and health systems.
- 07/30/2020
|
Allscripts Announces Second Quarter 2020 Results
- Allscripts Healthcare Solutions, Inc. (Nasdaq: MDRX) (Allscripts) announced its financial results for the three and six months ended June 30, 2020.
- 07/30/2020
|
New Strong Sell Stocks for July 29th
- Here are 5 stocks added to the Zacks Rank 5 (Strong Sell) List today.
- 07/29/2020
|
Analysts Estimate AllScripts Healthcare (MDRX) to Report a Decline in Earnings: What to Look Out for
- AllScripts (MDRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 07/23/2020
|
Allscripts clients dedicated to patient health throughout COVID-19 pandemic
- Since the beginning of the COVID-19 pandemic, Allscripts (NASDAQ: MDRX) and its clients have taken significant actions to ensure effective care delivery in the communities they serve. With unwavering dedication to patient health, caregivers from both large hospital systems and independent physician practices around the world continue to excel in the face of the unprecedented crisis to help manage their patients and combat the spread of the virus.
- 07/23/2020
|
Allscripts to Release Second-Quarter 2020 Financial Results July 30 | | IT Business Net
- CHICAGO--(BUSINESS WIRE)--#healthIT--Allscripts Healthcare Solutions, Inc. (Nasdaq:MDRX) will report its financial results for the three months ended June 30, 2020 after the close of stock market hour
- 07/21/2020
|
Allscripts to Release Second-Quarter 2020 Financial Results July 30
- Allscripts Healthcare Solutions, Inc. (Nasdaq:MDRX) will report its financial results for the three months ended June 30, 2020 after the close of stock market hours on Thursday, July 30, 2020. Allscripts management plans to host a conference call and webcast to discuss the company's earnings at 4:30 p.m. Eastern Time that same day. Allscripts will also provide a supplemental presentation with an update on the company’s margin improvement initiatives and segment reporting. The presentation will be available on the Allscripts investor relations website in advance of the call. The company will conduct an extended question and answer session following the prepared remarks.
- 07/21/2020
|
Why Allscripts Healthcare's Stock Is Trading Lower Today
- Allscripts Healthcare Solutions (NASDAQ: MDRX) shares are trading lower on Tuesday after Goldman Sachs downgraded the stock from Neutral to Sell and lowered its price target from $6.50 to $5.50 per share.Allscripts Healthcare Solutions provides information technology and offerings to acute and ambulatory providers as well as hospital services. The company supports electric medical records, private cloud hosting, and other clinical services that support patient engagement and better outcomes.Additionally, the company offers administrative tools and services to improve operations, such as practice management, revenue cycle management, and clinical care coordination. Allscripts was founded in 1986 and is headquartered in Chicago.Allscripts Healthcare shares were trading down 9.42% at $6.54 during the time of publication on Tuesday. The stock has a 52-week high of $11.82 and a 52-week low of $4.56.Latest Ratings for MDRX DateFirmActionFromTo Jul 2020Goldman SachsDowngradesNeutralSell May 2020Morgan StanleyMaintainsUnderweight May 2020SunTrust Robinson HumphreyMaintainsHold View More Analyst Ratings for MDRX View the Latest Analyst RatingsSee more from Benzinga * Why Wheaton Precious Metals Is Trading Higher Today * Hibbett Sports Spikes 20% On Q2 Sales Forecast * Why Akers Biosciences Is Trading Higher Today(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
- 07/21/2020
|
Morning Market Stats in 5 Minutes
- Movers
Indices
• S&P 500 ETF (NYSE:SPY) increased 0.70% to $326.54.
• Nasdaq ETF (NASDAQ:QQQ) fell 0.28% to $266.05.
• Dow Jones Industrial Average ETF (NYSE:...
- 07/21/2020
|
IQVIA and JDRF Collaborate to Improve Understanding of Type 1 Diabetes Using Real World Data
- IQVIA™ (NYSE: IQV) today announced it is joining forces with JDRF, the leading global organization funding type 1 diabetes (T1D) research, to use non-
- 07/20/2020
|
Global E-Prescription Industry to 2028 - Market Opportunities & Recommendations for New Investments - ResearchAndMarkets.com
|
Allscripts和微軟延長策略性聯盟關係以推動雲端型醫療IT解決方案的變革
- (美國商業資訊)--今天，Allscripts (MDRX: NASDAQ)和微軟公司宣佈延長雙方的長期策略性聯盟關係，以擴大雲端型醫療IT解決方案的開發和交付。五年的延長期將為Allscripts的雲端型Sunrise™電子健康記錄系統提供支援，也讓微軟成為該解決方案的雲端提供商，並開啟共同創新的
- 07/15/2020
|
Allscripts Extends Strategic Partnership With Microsoft
- Allscripts (MDRX) extends partnership with Microsoft that can help transform healthcare with smarter technology, thereby improving patient outcomes.
- 07/14/2020
|
Microsoft, Allscripts Dial Up Telehealth Growth | PYMNTS.com
- Microsoft and Allscripts are teaming up to expand "the delivery of cloud-based health IT solutions" as telehealth moves into the mainstream during the pandemic.
- 07/13/2020
|
Allscripts and Microsoft Extend Strategic Alliance to Transform Cloud-Based Health IT Solutions | | IT Business Net
- Five-year extension will support Allscripts' cloud-based Sunrise electronic health record and drive co-innovation CHICAGO & REDMOND, Wash.--(BUSINESS WIRE)--#healthIT--Today Allscripts (MDRX:
- 07/13/2020
|
Allscripts and Microsoft Extend Strategic Alliance to Transform Cloud-Based Health IT Solutions
- Today Allscripts (MDRX: NASDAQ) and Microsoft Corp. announced the extension of their long-standing strategic alliance to enable the expanded development and delivery of cloud-based health IT solutions. The five-year extension will support Allscripts’ cloud-based Sunrise™ electronic health record, making Microsoft the cloud provider for the solution and opening up co-innovation opportunities to help transform healthcare with smarter, more scalable technology. The alliance will enable Allscripts to harness the power of Microsoft’s platform and tools, including Microsoft Azure, Microsoft Teams and Power BI, creating a more seamless and highly productive user experience. Allscripts is an award-winning Microsoft partner with past recognitions including 2019 U.S. Healthcare Partner of the Year and 2017 Global Healthcare Partner of the Year (Public Sector), and most recently received Microsoft’s 2020 Health Innovation – Reimagine Healthcare award for its subsidiary 2bPrecise.
- 07/13/2020
|
Worldwide Wireless Electronic Health Records Industry to 2028 - Growth Prospects Among Emerging Nations - ResearchAndMarkets.com
|
3 Explosive Growth Stocks With Outstanding Management Teams
- Business conditions change over time, so betting on the right management team can be even more important than betting on the right company.
- 07/07/2020
|
Tyler Downs Joins Orb Health as Vice President of Engineering to Expand Innovative Virtual Chronic Care Management Services
- Orb Health announced that it has hired Tyler Downs as VP of Engineering to expand the architecture and capabilities of innovative platform.
- 07/07/2020
|
Two Sigma Advisers LP Acquires Shares of 110,903 Allscripts Healthcare Solutions Inc (NASDAQ:MDRX)
- Two Sigma Advisers LP acquired a new stake in shares of Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 110,903 shares of the software maker’s stock, valued at approximately $781,000. Two Sigma Advisers LP owned 0.07% […]
- 07/06/2020
|
Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) Expected to Earn FY2020 Earnings of $0.39 Per Share
- Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) – Stock analysts at Cantor Fitzgerald lowered their FY2020 earnings per share estimates for Allscripts Healthcare Solutions in a research note issued to investors on Thursday, July 2nd. Cantor Fitzgerald analyst S. Halper now forecasts that the software maker will post earnings of $0.39 per share for the year, down […]
- 07/04/2020
|
$20.7 Billion Worldwide Hospital EMR Systems Industry to 2025 - Impact of COVID-19 on the Market
- Dublin, July 02, 2020 (GLOBE NEWSWIRE) -- The "Hospital EMR Systems Market by Component (Software, Services, Hardware), Delivery Mode (Cloud,...
- 07/02/2020
|
Pollster With Fake Staff Gave Top Grades to Firms Landing Deals - BNN Bloomberg
- Everyone knows Yelp reviews are unscientific.
- 07/01/2020
|
Exela Technologies (NASDAQ:XELA) Announces Earnings Results
- Exela Technologies (NASDAQ:XELA) released its earnings results on Tuesday. The company reported ($0.08) EPS for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.03), MarketWatch Earnings reports. Shares of NASDAQ XELA opened at $0.55 on Wednesday. The company’s fifty day moving average is $0.42 and its 200-day moving average is $0.32. The stock has […]
- 07/01/2020
|
Exela Technologies, Inc. (XELA) Q1 2020 Earnings Call Transcript | The Motley Fool
- XELA earnings call for the period ending March 31, 2020.
- 07/01/2020
|
Here's Why You Should Retain Allscripts (MDRX) Stock for Now
- Allscripts (MDRX) continues to benefit from lucrative deals and strong prospects in Sunrise EHR. However, margin contraction remains a woe.
- 06/30/2020
|
CarePort Health Platform Shared by Hospitals and Post-Acute Care Partners to Ensure Safe COVID-19 Patient Transitions
- As hospitals across Michigan reached or exceeded capacity during the COVID-19 surge, the market-leading care coordination platform from CarePort Healt
- 06/30/2020
|
Cresco Labs Announces Retirement of Ken Amann and Appointment of Dennis Olis as Chief Financial Officer
- Mr. Amann to remain in an advisory role as part of the planned transitionCHICAGO — Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or “the Company”), one of the largest v…
- 06/25/2020
|
Cresco Labs Announces Retirement of Ken Amann and Appointment of Dennis Olis as Chief Financial Officer
- Cresco Labs Announces Retirement of Ken Amann and Appointment of Dennis Olis as Chief Financial Officer
- 06/25/2020
|
Hedge Funds Never Been Less Bullish On Allscripts Healthcare Solutions Inc (MDRX)
- We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of March 31st, near the height of the coronavirus market crash. In this article, we look at what those funds think […]
- 06/24/2020
|
Evonik Industries : Andreas Fischer is Evonik's new chief innovation officer | MarketScreener
|
The Global Care Management Solution Market is expected to grow from USD 10,434.14 Million in 2019 to USD 26,995.42 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 17.16%
- Market Segmentation & Coverage: This research report categorizes the Care Management Solution to forecast the revenues and analyze the trends in each of the following sub-markets:
- 06/24/2020
|
Allscripts' (MDRX) Veradigm Partners with PAN Foundation
- This partnership between Allscripts (MDRX) and PAN Foundation is expected to boost patient outcomes.
- 06/23/2020
|
Veradigm Supports Patient Access Network Foundation with New Awareness Campaign to Healthcare Providers
- Allscripts Healthcare Solutions (NASDAQ: MDRX) and its payer and life science business unit, Veradigm™, today announced a new partnership with the Patient Access Network (PAN) Foundation, an independent, national 501(c)(3) organization dedicated to helping federally and commercially insured people living with life-threatening, chronic and rare diseases with the out-of-pocket costs for their prescribed medications. Veradigm will leverage its market-leading electronic health record (EHR) messaging capabilities at no cost to the PAN Foundation, delivering information to users of its Veradigm ePrescribe and Practice Fusion EHR platforms to generate awareness and support utilization of the foundation’s programs among tens of thousands of clinicians.
- 06/22/2020
|
Veradigm Supports Patient Access Network Foundation with New Awareness Campaign to Healthcare Providers
- Allscripts Healthcare Solutions (NASDAQ: MDRX) and its payer and life science business unit, Veradigm™, today announced a new partnership with the Pat
- 06/22/2020
|
COVID-19 Impacts Demand on Ultraviolet (UV) Disinfection Equipment Market 2020-2024 | Evolving Opportunities With Advanced UV Inc. and American Ultraviolet Inc. | Technavio
|
Pandemic-related stress, isolation driving more to drink
- Your source for credible news and authoritative insights from Hong Kong, China and the world.
- 06/20/2020
|
COVID-19 Impacts Demand on Ultraviolet (UV) Disinfection Equipment Market 2020-2024 | Evolving Opportunities With Advanced UV Inc. and American Ultraviolet Inc. | Technavio
- The Global Ultraviolet (UV) Disinfection Equipment Market will grow by USD 2.06 bn during 2020-2024
- 06/20/2020
|
Assessment of COVID-19's Effect on Radiology Information Systems Market 2020-2024 | Increasing Demand for Cloud-Based Systems to Augment Growth | Technavio
|
E-prescribing Market Size worth USD 4,017.79 Million by 2026, growing at a 5.5% CAGR; Major Incorporation by EHR Solutions to Propel Demand: Fortune Business Insights™
- The global e-prescribing market size is expected to touch USD 4,017.79 million by the end of 2026, attributable to the incorporation of e-prescribing software
- 06/19/2020
|
Assessment of COVID-19's Effect on Radiology Information Systems Market 2020-2024 | Increasing Demand for Cloud-Based Systems to Augment Growth | Technavio
- The Global Radiology Information Systems Market will grow by USD 114.97 mn during 2020-2024
- 06/19/2020
|
3 Digital HealthCare Stocks in the Spotlight Amid Coronavirus
- In the face of the pandemic, the digital health management space continues to thrive on a number of positive developments.
- 06/18/2020
|
Massachusetts Financial Services Co. MA Purchases 6,021 Shares of Allscripts Healthcare Solutions Inc (NASDAQ:MDRX)
- Massachusetts Financial Services Co. MA boosted its position in Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) by 18.8% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 38,028 shares of the software maker’s stock after buying an additional 6,021 shares during the period. Massachusetts Financial […]
- 06/18/2020
|
Roche Pharma India expands partnership with Cipla for key oncology medicines
- Drug firm Roche Pharma India on Thursday said it has expanded its partnership with domestic pharma major Cipla to further improve access to its key oncology medicines in India.
In another development, Roche Pharma India said that it has partnered with Entero Healthcare Solutions to improve access to nephrology medicines in India.
- 06/18/2020
|
Global Digital Medicine Market is estimated to be US$ 18.6 Billion by 2029 with a CAGR of 23.5% during the Forecast Period - PMI
- The global digital medicine market accounted for US$ 2.3 billion in 2019 and is estimated to be US$ 18.6 billion by 2029 and is anticipated to register a CAGR
- 06/17/2020
|
Burden of COVID-19 on the Market & Rehabilitation Plan | Healthcare Revenue Cycle Management (RCM) Software Market 2019-2023 | Rise in Adoption of Electronic Health Record (EHR) to Boost Growth | Technavio
- The Global Healthcare Revenue Cycle Management (RCM) Software Market will grow by $ 1.49 bn during 2019-2023
- 06/17/2020
|
OptimizeRx May Be Well-Positioned For The Pandemic, Or Not (NASDAQ:OPRX)
- Strong YoY quarterly revenue growth of 46%. As a digital health technology business, OptimizeRx should be well-positioned for the current market conditions. Sig
- 06/16/2020
|
Allscripts (MDRX) Looks Good: Stock Adds 9.1% in Session
- Allscripts (MDRX) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.
- 06/16/2020
|
DarioHealth (NASDAQ:DRIO) Receives News Impact Score of -3.53
- News articles about DarioHealth (NASDAQ:DRIO) have been trending very negative recently, according to InfoTrie Sentiment Analysis. InfoTrie identifies positive and negative press coverage by analyzing more than 6,000 news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five […]
- 06/16/2020
|
Acessa Health Adds Three Executives to Leadership Team
- Acessa Health Inc. is proud to announce the addition of three new executive team members.
- 06/16/2020
|
Fact check: 35,000 “malnourished” and “caged” children were not recently rescued from tunnels by U.S. military
- Viral claims on social media purport that a recent U.S. military operation rescued 35,000 “malnourished, caged and tortured” children from tunnels beneath New York City’s Central Park and other unnamed U.S. cities. There is no evidence to prove key aspects of this conspiracy claim.
- 06/15/2020
|
Zacks Investment Research Upgrades Exela Technologies (NASDAQ:XELA) to Buy
- Exela Technologies (NASDAQ:XELA) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued on Saturday, Zacks.com reports. The brokerage presently has a $1.00 price objective on the stock. Zacks Investment Research‘s price target points to a potential upside of 117.34% from the company’s current price. According […]
- 06/15/2020
|
S&P Dow Jones Indices Announces Tyler Technologies, Bio-Rad Laboratories and Teledyne Technologies Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
- S&P; Dow Jones Indices will make the following index adjustments to the S&P; 500, S&P; MidCap 400 and S&P; SmallCap 600 to ensure each index more appropriately represents its market capitalization range. The changes will be effective prior to the open of trading on Monday, June 22 to coincide with the June quarterly rebalance.
- 06/12/2020
|
Global Telemedicine Services Market To Reach Value Of $78 Billion In 2023
- Telemedicine Services Market Global Report 2020-30: Covid 19 Growth And Change
- 06/12/2020
|
Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) Shares Bought by State Street Corp
- State Street Corp raised its stake in Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) by 5.3% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 5,468,496 shares of the software maker’s stock after acquiring an additional 277,072 shares during the quarter. State Street Corp […]
- 06/10/2020
|
Clinical Workflow Solutions Market to Register Significant Gains Over 2020 to 2027
- Jun 09, 2020 (Global QYResearch via COMTEX) --
The global Clinical Workflow Solutions Market size is expected to reach USD 15.1 billion by 2027, at a...
- 06/09/2020
|
Shares of several healthcare companies are trading higher on continued optimism amid the reopening of the economy, which would increase consumer spending and economic activity.
|
AllScripts (MDRX) Up 18% Since Last Earnings Report: Can It Continue?
- AllScripts (MDRX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- 06/06/2020
|
Practice Management System Market Size, Share, Technology, Cost, Revenue, Region, Applications and Forecast to 2026
- Jun 05, 2020 (CDN Newswire via Comtex) --
The global Practice Management System market focuses on encompassing major statistical evidence for the Practice...
- 06/05/2020
|
Global Clinical Healthcare Analytics Services Market 2020 by Key Players, Segmentation, Industry Growth, Opportunities and Forecast by 2026
- Jun 03, 2020 (CDN Newswire via Comtex) --
The currently appended report by MarketsandResearch.biz with the title Global Clinical Healthcare Analytics...
- 06/03/2020
|
Allscripts Names New Director to Board
- Beth Altman has been appointed to the Board of Directors of Allscripts Healthcare Solutions, Inc. A former executive at accounting firm KPMG LLP, Altman has more than 25 years of experience in accounting, finance, management, business development, strategic planning and corporate governance. Most recently and until her retirement in 2019, Altman led a team of more than 260 to provide assurance, tax and advisory services to public and private companies spanning all industry sectors. She will serve as a member of the Audit Committee of the Board.
- 06/02/2020
|
Global Healthcare Analytics Market by Component, Deployment Mode, Type, Application, End-user and Region - Forecast to 2025 - ResearchAndMarkets.com
|
My Best Play On Fundamentals Is MTBC (NASDAQ:MTBC)
- MTBC has a proven business plan. A recent acquisition of a high growth technology disruptor will ramp up margins and revenues at a faster pace. The new telemedi
- 06/01/2020
|
Digital Health Monitoring Devices Market Analysis as per the Latest Coronavirus Impact
- Jun 01, 2020 (Heraldkeepers) --
New York, June 01, 2020: Market Research Engine has published a new report titled as "Digital Health Monitoring Devices...
- 06/01/2020
|
Covetrus Announces Chief Product Officer for Global Technology Solutions
- Covetrus has named Arman Samani to the role of chief product officer (CPO).
- 06/01/2020
|
North American Healthcare Analytics Market Growth, Trends, and Forecasts 2020-2025, with Leading Players 3M, Allscripts Healthcare Solutions and Philips Healthcare - ResearchAndMarkets.com
|
How 1mg Is Democratising AI & ML In Healthcare Delivery
- Healthcare is one of the fastest-growing sectors in the country and is expected to reach $372 billion by the year 2022 as per an IBEF report. Along with artificial intelligence, there are multiple factors driving this growth — an increase in government spending on healthcare, rise in the purchasing power of the population, rapid urbanisation…
- 05/27/2020
|
COVID-19 Impact on Healthcare Analytics Market
- May 26, 2020 (Heraldkeepers) --
New York, May 26, 2020: You will get latest updated report as per the COVID-19 Impact on this industry. Our updated reports...
- 05/26/2020
|
Global Digital Health Industry (2019 to 2027) - Market Trajectory & Analytics - ResearchAndMarkets.com
|
Research Report with COVID-19 Forecasts - Healthcare Cloud Computing Market 2020-2024 | Development of Hyper-Converged Infrastructure to Boost Growth | Technavio
- Technavio has been monitoring the healthcare cloud computing market and it is poised to grow by USD 25.54 billion during 2020-2024, progressing at a CAGR of...
- 05/25/2020
|
Research Report with COVID-19 Forecasts - Healthcare Cloud Computing Market 2020-2024 | Development of Hyper-Converged Infrastructure to Boost Growth | Technavio
- The healthcare cloud computing market size has the potential to grow by USD 25.54 billion during 2020-2024
- 05/25/2020
|
Allscripts U.K. client Gloucestershire Hospitals achieves successful go-live with e-observations solution amidst COVID-19 pandemic
- Gloucestershire Hospitals NHS Foundation Trust, located in the United Kingdom, has successfully gone live with the latest addition to its Allscripts electronic health record, despite the ongoing novel coronavirus outbreak.
- 05/21/2020
|
2bPrecise honored as recipient of the 2020 Microsoft Health Innovation Awards
- 2bPrecise™ Precision Health™ platform named recipient of Microsoft’s 2020 Health Innovation Awards in the "Reimagine Healthcare" category.
- 05/20/2020
|
2bPrecise honored as recipient of the 2020 Microsoft Health Innovation Awards
- 2bPrecise™ Precision Health™ platform named recipient of Microsoft’s 2020 Health Innovation Awards in the “Reimagine Healthcare
- 05/20/2020
|
Microsoft to adapt its cloud software for healthcare industry
- Microsoft Corp said on Tuesday it plans to roll out a version of its cloud-based software that will be modified to suit the needs of healthcare organizations. While Microsoft is known for general productivity software such as Outlook and the chat app Teams, it also makes more specialized business software such as programs used by customer service agents and artificial intelligence tools that software developers can use to make chat bots. Microsoft said it will pull all of its technologies together into a package it calls "Microsoft Cloud for Healthcare."
- 05/19/2020
|
Allscripts Unit Inks Deal to Boost Veradigm AccelRx Platform
- This deal is expected to bolster Allscripts' (MDRX) Clinical and Financial Solutions segment.
- 05/19/2020
|
Sunnybrook Health Sciences Centre Extends Relationship with Allscripts, Incorporating Allscripts Census Logic Analytics and Managed Services
- Allscripts Healthcare Solutions (NASDAQ: MDRX) today announces that Canada’s Sunnybrook Health Sciences Centre has extended its relationship with Allscripts for an additional seven years to provide software and support for Allscripts Patient Flow. This extension includes the purchase by Sunnybrook of Allscripts Managed Services to manage the Patient Flow solution 24 hours, seven days a week and 365 days a year. The Allscripts Managed Services team will optimize the solution, implement customizations and new functionality and assist with change control and expansion activities.
- 05/19/2020
|
Sunnybrook Health Sciences Centre Extends Relationship with Allscripts, Incorporating Allscripts Census Logic Analytics and Managed Services
- Allscripts Healthcare Solutions (NASDAQ: MDRX) today announces that Canada’s Sunnybrook Health Sciences Centre has extended its relationship with Alls
- 05/19/2020
|
Stocks Amid COVID-19 Outbreak: Winners So Far in the Health Industry
- At its worst on March 23rd, Dow Jones and the S&P; declined by around 37% and 34%. At the time, those kinds of numbers represented a loss of a 3-year gain since Trump’s election in November of 2016. Measured by VIX, market volatility spiked by 43% in March, reaching levels that are comparable to the […]
- 05/18/2020
|
Shares of several healthcare companies are trading higher in sympathy with the overall market as optimism around a coronavirus vaccine increased following news from Moderna.
|
Edited Transcript of MDRX earnings conference call or presentation 7-May-20 8:30pm GMT
- Q1 2020 Allscripts Healthcare Solutions Inc Earnings Call
- 05/15/2020
|
Patient Access Solutions Market Forecast & Opportunities to 2025 - ResearchAndMarkets.com
|
Allscripts Receives Top Rankings From Black Book™ Research
- Allscripts (NASDAQ: MDRX) has been recognized as the top-rated electronic health record vendor for ambulatory practices and inpatient hospitals according to new survey results from Black Book Research. The annual client satisfaction survey features responses collected from more than 2,000 individual users of electronic health record platforms in the U.S. and are collected from all areas of the organization including IT, administrative staff and end-user clinicians.
- 05/14/2020
|
Allscripts Receives Top Rankings From Black Book™ Research
- Allscripts (NASDAQ: MDRX) has been recognized as the top-rated electronic health record vendor for ambulatory practices and inpatient hospitals accord
- 05/14/2020
|
Shares of several companies in the broader healthcare sector are trading lower amid market weakness despite recent strength from many names in the space. Equities are down for the session following cautious comments from US Fed Chair Powell, which forecast uncertainty and downside risk. Some regions of the US have extended lockdown restrictions, including Washington D.C. and Los Angeles County.
|
Morgan Stanley Maintains Underweight on Allscripts Healthcare, Raises Price Target to $6
|
SunTrust Robinson Humphrey Maintains Hold on Allscripts Healthcare, Raises Price Target to $7
|
Analysis on Impact of COVID-19 - Global Ultraviolet (UV) Disinfection Equipment Market 2020-2024 | Evolving Opportunities with Advanced UV Inc. and American Ultraviolet Inc. | Technavio
- The ultraviolet (UV) disinfection equipment is poised to grow by USD 2.06 bn during 2020-2024, according to Technavio
- 05/13/2020
|
Allscripts (MDRX) Q1 Earnings and Revenues Miss Estimates
- Allscripts (MDRX) witnessed a decline in core Client Services and Software delivery unit revenues in Q1.
- 05/12/2020
|
Veradigm, Surescripts Partner to Reduce Time-to-Fill for Specialty Medication Prescriptions
- Allscripts (NASDAQ: MDRX) business unit Veradigm™, a leading provider of data and technology solutions, today announced the signing of an agreement with Surescripts to enhance its Veradigm AccelRx™ specialty medication fulfillment solution with Surescripts Specialty Patient Enrollment. The agreement will enable AccelRx to support healthcare providers in more quickly fulfilling prescriptions for hundreds more types of specialty medications by incorporating Surescripts’ expansive health information network, further streamlining healthcare providers’ management of specialty medication within their electronic health record workflow.
- 05/12/2020
|
Veradigm, Surescripts Partner to Reduce Time-to-Fill for Specialty Medication Prescriptions
- Allscripts (NASDAQ: MDRX) business unit Veradigm™, a leading provider of data and technology solutions, today announced the signing of an agreement wi
- 05/12/2020
|
U.S. RESEARCH ROUNDUP-Acushnet Holdings, Equity Residential, Fiserv
- Wall Street securities analysts revised their ratings and price targets
on several U.S.-listed companies, including Acushnet Holdings, Equity Residential and Fiserv, on
Monday.
HIGHLIGHTS
* Acushnet Holdings Corp : Stephens raises target price to $27 from $24
* Equity Residential : Evercore ISI raises to in-line from underperform
* Fiserv Inc : Keybanc raises target price to $115 from $108
* GTT Communications Inc : SunTrust Robinson cuts to hold from buy
* UDR Inc : Evercore ISI raises to in-line from underperform
Following is a summary of research actions on U.S. companies reported by Reuters on Monday.
Stock entries are in alphabetical order.
* Abbvie Inc : SVB Leerink raises price target to $122 from $107
* Accelerate Diagnostics Inc : Piper Sandler cuts target price to $14 from $16
* Acushnet Holdings Corp : Compass Point raises TP to $22.25 from $21.50
* Acushnet Holdings Corp : Keybanc raises target price to $31 from $28
* Acushnet Holdings Corp : Stephens raises target price to $27 from $24
* Advance Auto Parts Inc : UBS raises target price to $140 from $135
* AIG : UBS cuts target price to $45 from $49
* Air Lease Corp : Deutsche Bank cuts target price to $36 from $45
* Air Lease Corp : Stephens raises target price to $36 from $30
* Airgain Inc : Northland Capital Markets raises target price to $23
* Alarm.Com Holdings Inc : Credit Suisse cuts target price to $62 from $64
* Albemarle Corp : RBC raises target price to $66 from $64
* Albemarle Corp : SunTrust Robinson cuts target price to $65 from $90
* Allegiant Travel Co : Evercore ISI cuts target price to $95 from $100
* Allscripts Healthcare Solutions : Canaccord Genuity cuts TP to $11 from $13
* Amdocs Ltd : Citigroup cuts price target to $76 from $83
* Amedisys Inc : Raymond James cuts price target to $210 from $225
* Amedisys Inc : UBS cuts target price to $190 from $208
* American Axle & Manufacturing Holdings : Citigroup raises TP to $7.5 from $6
* American Axle & Manufacturing Holdings : RBC raises target price to $7 from $5
* American Homes 4 Rent : Evercore ISI raises target price to $27 from $25
* Ameriprise Financial Inc : RBC raises target price to $155 from $145
* Amerisourcebergen Corp : Deutsche Bank raises target price to $98 from $93
* Amphastar Pharmaceuticals Inc : BMO raises price target to $21 from $20
* Angi Homeservices Inc : Citigroup raises price target to $10 from $6.5
* Aon Plc : Citigroup cuts price target to $230 from $240
* Aon Plc : KBW raises target price to $192 from $184
* Aon Plc : UBS cuts target price to $197 from $202
* Apache Corp : CFRA cuts to sell from hold; raises price target to $9
* Apache Corp : MKM Partners cuts target price by $1 to $19
* Aptiv Plc : Benchmark cuts price target to $87 from $90
* Arch Capital Group Ltd : UBS cuts target price to $39 from $43
* Atara Biotherapeutics Inc : Jefferies cuts target price to $11 from $13
* Athene Holding Ltd : BMO cuts price target to $60 from $63
* Atricure Inc : BTIG raises target price to $56 from $45
* Atricure Inc : Needham raises target price to $63 from $49
* Atricure Inc : Oppenheimer raises price target to $52 from $45
* Atricure Inc : SVB Leerink raises price target to $55 from $50
* Autonation Inc : CFRA cuts price target by $10 to $50
* Avalonbay Communities Inc : Evercore ISI cuts target price to $181 from $189
* Avista Corp : Guggenheim cuts target price to $38 from $39
* Bain Capital Specialty Finance : Citigroup raises price target to $10 from $7.5
* Ball Corp : Citigroup cuts price target to $86 from $89
* Ball Corp : Northland Capital Markets cuts target price to $80
* Baudax Bio Inc : Oppenheimer cuts price target to $14 from $16
* Bellring Brands Inc : Stifel cuts target price to $23 from $25
* BJ's Restaurants Inc : Deutsche Bank raises target price to $27 from $26
* Bloomin' Brands Inc : BMO raises price target to $10 from $9
* Bloomin' Brands Inc : Deutsche Bank raises target price to $15 from $14
* Bloomin' Brands Inc : Guggenheim raises target price to $15 from $11
* Bloomin' Brands Inc : Raymond James cuts target price to $14 from $15
* BP Midstream Partners LP : Mizuho raises target price to $14 from $13
* Broadridge Financial Solutions : Piper Sandler cuts TP to $120 from $124
* Broadridge Financial Solutions : Rosenblatt Securities ups TP to $115 from $101
* Brookfield Infrastructure Partners LP : BMO raises price target to $46 from $45
* Brookfield Infrastructure Partners LP : Scotiabank cuts Tp to $50 from $51
* Brookfield Property Partners LP : Canaccord Genuity cuts TP to $12 from $13
* Brookfield Property Partners LP : CIBC cuts target price to $18 from $20.50
* Brookfield Property Partners LP : RBC cuts target price to $18 from $22
* Bruker Corp : BTIG cuts price target to $50 from $57
* Cabot Oil & Gas Corp : Tudor Pickering Holt cuts to hold from buy
* Calithera Biosciences Inc : Citigroup raises price target to $10 from $7
* Callaway Golf Co : >: Compass Point cuts target price to $17.50 from $20
* Callaway Golf Co : Compass Point cuts target price to $17.50 from $20
* Camden Property Trust : Evercore ISI cuts target price to $98 from $102
* Camden Property Trust : Stifel raises target price to $96 from $91
* Cardtronics Plc : D.A. Davidson cuts target price to $34 from $40
* Cardtronics Plc : SunTrust Robinson raises target price to $29 from $23
* Cargurus Inc : RBC raises target price to $25 from $22
* Carnival : HSBC raises to buy from hold; cuts target price to $15.9 from $45.3
* Carrier Global Corp : Citigroup raises price target to $20 from $17
* Carvana Co : Oppenheimer raises price target to $127 from $95
* Carvana Co : Oppenheimer raises target price to $127 from $95
* Casella Waste Systems Inc : Jefferies raises target price to $56 from $52
* Casella Waste Systems Inc : Raymond James raises target price to $56 from $49
* Casella Waste Systems Inc : Stifel raises target price to $47 from $45
* Cellectis : Citigroup cuts price target to $15 from $16
* Centurylink Inc : SunTrust Robinson cuts target price to $9 from $10
* Ceridian Hcm Holding Inc : Jefferies raises target price to $65 from $60
* Chevron Corp : Independent Research raises target price to $98 from $90; hold
* CNX Resources Corp : Tudor Pickering Holt cuts to hold from buy
* Cognizant Technology Solutions : Evercore ISI cuts target price to $53 from $55
* Cognizant Technology Solutions Corp : HSBC cuts target price to $56 from $70
* Coherus Biosciences Inc : Citigroup cuts price target to $30 from $31
* Conagra Brands Inc : SunTrust Robinson cuts to hold from buy
* Consolidated Edison Inc : Evercore ISI cuts target price to $85 from $86
* Continental Resources : TD Securities raises target price to $14.50 from $13.50
* Cooper Tire & Rubber Co : JP Morgan cuts target price to $29 from $30
* Corporate Office Properties Trust : SunTrust Robinson raises TP to $28 from $26
* Corteva Inc : RBC raises target price to $31 from $27
* Covanta Holding : Stifel raises to hold from sell; raises TP to $9.50 from $6.50
* Crocs Inc : Piper Sandler raises target price to $28 from $24
* Cross Country Healthcare Inc : BMO cuts price target to $8 from $11
* Cryoport Inc : Stephens raises target price to $23 from $21
* CVR Energy Inc : Credit Suisse raises target price to $19 from $16
* Cytomx Therapeutics Inc : Wedbush raises target price to $16 from $11
* Danaher Corp : Evercore ISI raises target price to $175 from $150
* Danaher Corp : RBC raises target price to $173 from $159
* Datadog Inc : RBC raises target price to $50 from $43
* Dentsply Sirona : Barrington Research cuts to market perform from outperform
* Dentsply Sirona Inc : UBS cuts target price to $44 from $59
* Dicerna Pharmaceuticals : SunTrust Robinson raises target price to $33 from $28
* Diebold Nixdorf Inc : JP Morgan raises target price to $7 from $6
* Diebold Nixdorf Inc : JP Morgan raises to neutral from underweight
* Discovery Inc : Rosenblatt Securities cuts price target to $24 from $27
* Dish Network Corp : RBC cuts target price to $32 from $39
* Domtar : D.A. Davidson cuts to neutral from buy; cuts TP to $26 from $44
* Domtar Corp : Scotiabank cuts target price to $29 from $30
* Domtar Corp : TD Securities raises target price to $26 from $22
* E. W. Scripps Co : Benchmark cuts target price to $15 from $24
* E. W. Scripps Co : Guggenheim raises target price to $8 from $6.50
* Edison Intl.
- 05/11/2020
|
HMS Holdings Corp (NASDAQ: HMSY) Q1 2020 Earnings Call Transcript | AlphaStreet
- Final earnings conference call transcript of HMS Holdings Corp - HMSY stock
- 05/11/2020
|
The Gloal Population Health Management Market is Forecast to Reach USD 150.6 billion by 2027 - ResearchAndMarkets.com
|
HMS Holdings Corp. (HMSY) CEO Bill Lucia on Q1 2020 Results - Earnings Call Transcript
- HMS Holdings Corp. (NASDAQ:HMSY) Q1 2020 Earnings Conference Call May 8, 2020 08:30 ET Company Participants Robert Borchert - Head, Investor Relations Bill Luci
- 05/09/2020
|
Allscripts Healthcare Solutions, Inc. (MDRX) CEO Paul Black on Q1 2020 Results - Earnings Call Transcript
- Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Q1 2020 Earnings Conference Call May 7, 2020 4:30 p.m. ET Company Participants Stephen Shulstein - VP, IR Pa
- 05/09/2020
|
Allscripts (MDRX) Q1 2020 Earnings Call Transcript
- MDRX earnings call for the period ending March 31, 2020.
- 05/08/2020
|
Modular Ambulatory Software Market Overview, Manufacturing Cost Structure Analysis, Growth Opportunities and Restraint to 2024
- May 08, 2020 (The Expresswire) --
The “Modular Ambulatory Software Market” report entitled “Global Modular Ambulatory Software Market Growth (Status and...
- 05/08/2020
|
Ambulatory Surgery Center Software Solutions Market Analysis including Size, Share, Key Drivers, Growth Opportunities and Trends 2020 – 2024
- May 08, 2020 (The Expresswire) --
Global “Ambulatory Surgery Center Software Solutions Market “report provides comprehensive coverage on major industry...
- 05/08/2020
|
SVB Leerink Maintains Market Perform on Allscripts Healthcare, Lowers Price Target to $6
|
U.S. RESEARCH ROUNDUP-Becton Dickinson, Epam Systems, PayPal Holdings
- Wall Street securities analysts on Friday revised their ratings and price targets on several
U.S.-listed companies, including Becton Dickinson, Epam Systems and PayPal Holdings.
HIGHLIGHTS
* Becton Dickinson and Co : Citigroup raises price target to $260 from $234
* Carrols Restaurant Group Inc : Craig-Hallum raises to buy from hold; raises target price to $5 from $3.75
* Computer Programs and Systems Inc : Cantor Fitzgerald raises to overweight from neutral
* Epam Systems Inc : Citigroup raises price target to $265 from $245
* PayPal Holdings Inc : Citigroup raises price target to $145 from $131
Following is a summary of research actions on U.S. companies reported by Reuters on Friday. Stock entries are in alphabetical
order.
* Aaron's Inc : Keybanc cuts target price to $55 from $66
* Aaron's Inc : Raymond James cuts target price to $50 from $60
* Aaron's Inc : Stephens raises target price to $45 from $26
* Abeona Therapeutics Inc : RBC cuts target price to $7 from $11
* Acceleron pharma Inc : Credit Suisse raises target price to $123 from $99
* ACI Worldwide Inc : Canaccord Genuity cuts target price to $35 from $44
* Acushnet Holdings Corp : Jefferies raises target price to $25 from $24
* Acushnet Holdings Corp : JP Morgan raises target price to $30 from $27
* Adtran Inc : Cowen and Company raises price target to $13 from $9
* Aeglea Bio Therapeutics Inc : Needham cuts price target to $11 from $14
* Aerie Pharmaceuticals Inc : Citigroup cuts price target to $38 from $39
* Agco Corp : Citigroup cuts price target to $55 from $57
* AIG : KBW raises target price to $36 from $35
* Alaska Air Group Inc : Credit Suisse cuts target price to $51 from $82
* Allison Transmission Holdings Inc : Citigroup raises price target to $39 from $38
* Allscripts Healthcare Solutions : Cantor Fitzgerald cuts PT to $6 from $8
* Alteryx Inc : Guggenheim cuts target price to $130 from $160
* American Airlines : Credit Suisse cuts target price to $4 from $26
* Ameriprise Financial Inc : Credit Suisse raises target price to $165 from $153
* Ameriprise Financial Inc : Piper Sandler raises target price to $150 from $130
* Amerisourcebergen Corp : Baird raises target price to $115 from $109
* Amerisourcebergen Corp : Mizuho raises target price to $90 from $85
* Amtech Systems Inc : Cowen and Company raises target price to $7.50 from $7
* Angi Homeservices Inc : Needham raises target price to $11 from $8
* Ani Pharmaceuticals Inc : Guggenheim cuts target price to $48 from $58
* Ansys Inc : RBC raises target price to $260 from $230
* Anthem Inc : Bernstein raises target price to $357 from $342
* Appian Corp : Cowen and Company raises price target to $44 from $39
* Applied Optoelectronics Inc : D.A. Davidson raises target price to $12 from $10
* Applied Optoelectronics Inc : Piper Sandler raises target price to $10 from $7.50
* Aptiv Plc : Citigroup raises price target to $84 from $67
* ArcelorMittal SA : Keybanc raises target price to $15 from $13
* Arcturus Therapeutics Holdings Inc : Baird raises target price to $44 from $26
* Arcturus Therapeutics Holdings Inc : Guggenheim raises target price to $51 from $41
* Ares Capital Corp : Citigroup raises price target to $15 from $13
* Athersys Inc : Needham cuts price target to $5 from $6
* Atlas Air Worldwide Holdings Inc : Cowen and Company raises PT to $44 from $40
* Avalara Inc : Canaccord Genuity raises target price to $115 from $105
* Avalara Inc : JP Morgan raises target price to $120 from $104
* Avalara Inc : Mizuho raises price target to $120 from $85
* Avalara Inc : Piper Sandler raises target price to $113 from $90
* Avalonbay Communities Inc : Stifel raises target price to $176 from $171
* Avrobio Inc : Guggenheim raises target price to $50 from $49
* Axalta Coating Systems Ltd : RBC raises target price to $21 from $20
* Bausch Health Companies Inc : Piper Sandler cuts target price to $32 from $34
* Beacon Roofing Supply Inc : SunTrust Robinson raises target price to $26 from $24
* Beacon Roofing Supply Inc : Wedbush raises target price to $23 from $16
* Becton Dickinson and Co : Citigroup raises price target to $260 from $234
* Becton Dickinson and Co : Evercore ISI raises target price to $270 from $255
* Beyond Meat Inc : Berenberg raises price target to $125 from $115
* Bill.Com Holdings Inc : Canaccord Genuity raises target price to $65 from $50
* Bill.Com Holdings Inc : Jefferies raises target price to $70 from $45
* Bill.Com Holdings Inc : Keybanc raises target price to $76 from $60
* Bill.Com Holdings Inc : Needham raises target price to $90 from $55
* Biomarin Pharmaceutical Inc : Canaccord Genuity raises PT to $119 from $108
* BJ's Restaurants Inc : Wedbush cuts target price to $32 from $39
* Booking Holdings Inc : Credit Suisse raises target price to $1,810 from $1,790
* Booking Holdings Inc : Jefferies cuts target price to $1300 from $1350
* Booking Holdings Inc : Mizuho cuts price target to $1700 from $1720
* Booking Holdings Inc : RBC raises target price to $1,550 from $1,535
* Booking Holdings Inc : RBC raises target price to $1550 from $1535
* BorgWarner Inc : Citigroup raises price target to $30 from $23
* BorgWarner Inc : Credit Suisse raises target price to $33 from $31
* Bottomline Technologies (De) Inc : Citigroup raises price target to $46 from $43
* Bright Horizons Family Solutions Inc : Citigroup raises PT to $122 from $80
* Brightsphere Investment Group Inc : Evercore ISI raises target to $9 from $6
* Brightsphere Investment Group Inc : KBW raises target price to $9.50 from $7.25
* Brightview Holdings Inc : Credit Suisse cuts target price to $14 from $18
* Brightview Holdings Inc : Jefferies raises target price to $14 from $12
* Cabot Microelectronics Corp : Citigroup cuts price target to $140 from $175
* Cactus Inc : zephirin Group raises price objective to $12 from $8
* Calithera Biosciences Inc : Jefferies raises target price to $9 from $6
* Calyxt Inc : BMO cuts price target to $7 from $13
* Calyxt Inc : BMO cuts to market perform from outperform
* Camping World Holdings Inc : Credit Suisse raises target price to $12 from $11
* Camping World Holdings Inc : JP Morgan raises price target to $11 from $10
* Capstar Financial Holdings Inc : KBW raises target price to $11 from $10.50
* Cargurus Inc : BTIG raises target price to $26 from $23
* Carrols Restaurant Group Inc : Craig-Hallum raises to buy from hold; raises target price to $5 from $3.75
* Castlight Health Inc : Cantor Fitzgerald cuts target price to $1 from $2
* Catasys Inc : Canaccord Genuity raises target price to $36 from $35
* CBRE Group Inc : Evercore ISI cuts target price to $48 from $50
* CBRE Group Inc : KBW cuts target price to $51 from $52
* Centerpoint Energy Inc : Guggenheim raises target price to $26 from $25
* Centerpoint Energy Inc : Keybanc raises target price to $16 from $12
* Centurylink Inc : RBC cuts target price to $10 from $14
* CF Industries Holdings Inc : Citigroup cuts price target to $29 from $31
* CF Industries Holdings Inc : Scotiabank raises target price to $32 from $31
* ChannelAdvisor Corp : Needham raises price target to $14 from $11
* Charles River Laboratories International : Credit Suisse cuts PT to $159 from $162
* Charles River Laboratories International : Evercore ISI ups PT to $176 from $154
* Charles River Laboratories International : Jefferies raises PT to $161 from $139
* Charles River Laboratories International Inc : Citigroup raises price target to $190 from $165
* Chart Industries Inc : zephirin Group raises price objective to $25 from $17
* Charter Communications Inc : Benchmark raises price target to $600 from $523
* Chemours Co : Citigroup raises price target to $13 from $8
* Cimarex Energy Co : MKM Partners raises target price to $34 from $31
* City Holding Co : Stephens cuts target price to $63 from $64.
- 05/08/2020
|
Cantor Fitzgerald Reiterates Neutral on Allscripts Healthcare, Lowers Price Target to $6
|
Edited Transcript of MDRX earnings conference call or presentation 7-May-20 8:30pm GMT
- Q1 2020 Allscripts Healthcare Solutions Inc Earnings Call
- 05/08/2020
|
Global Virtual Healthcare Delivery Market (2020 to 2026) - The WHO Recommended Using Virtual Healthcare Delivery to Evaluate Suspected Cases of COVID-19 - ResearchAndMarkets.com
|
AllScripts Healthcare (MDRX) Q1 Earnings and Revenues Miss Estimates
- AllScripts (MDRX) delivered earnings and revenue surprises of -35.71% and -1.17%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
- 05/07/2020
|
Allscripts Healthcare Q1 Adj. EPS $0.090 Misses $0.150 Estimate, Sales $417.000M Miss $423.060M Estimate
|
Allscripts Announces First Quarter 2020 Results
- Allscripts Healthcare Solutions, Inc. (Nasdaq: MDRX) (Allscripts) announced its financial results for the three months ended March 31, 2020.
- 05/07/2020
|
Phreesia Adapts To New Operating Environment But Visibility Awaits
- Phreesia went public in July 2019, raising $167 million in gross proceeds in an IPO. The firm provides patient intake and communications software to healthcare
- 05/07/2020
|
Patient Engagement Solutions Market Trends 2020, Cost Estimation, Size Analysis and Sales Projection By 2025
- May 07, 2020 (Heraldkeepers) --
Patient Engagement Solutions Market Scope The patient engagement solutions market report contains a comprehensive analysis of...
- 05/07/2020
|
Automatic Pill Dispensing Systems Market: Business Opportunities, Current Trends, Market Challenges & Global Industry Analysis by 2026
- May 07, 2020 (The Expresswire) --
Global “Automatic Pill Dispensing Systems Market ” analysis 2020 covers the entire supply chain, focusing on supply,...
- 05/07/2020
|
Earnings Scheduled For May 7, 2020
|
Allscripts Tops Competitors in New Client Satisfaction Report From Black Book™ Research
- Allscripts (NASDAQ: MDRX) has been recognized as the top-rated inpatient EHR vendor for hospitals 101-250 beds, according to new survey results from Black Book Research.
- 05/06/2020
|
Such Is Life: How Allscripts Healthcare Solutions (NASDAQ:MDRX) Shareholders Saw Their Shares Drop 59%
- We think intelligent long term investing is the way to go. But that doesn't mean long term investors can avoid big...
- 05/06/2020
|
Allscripts Announces Move to Virtual Format for 2020 Annual Meeting of Stockholders
- Allscripts Healthcare Solutions, Inc. (Nasdaq: MDRX) today announced that, due to the public health impact of the novel coronavirus (COVID-19) pandemic, related governmental actions and the importance of safeguarding the health of its stockholders, employees and representatives, Allscripts will hold its 2020 Annual Meeting of Stockholders (the "Annual Meeting") solely by means of remote communication (i.e., a virtual-only meeting). Stockholders will not be able to attend the Annual Meeting in person.
- 05/05/2020
|
U.S. RESEARCH ROUNDUP-Berkshire Hathaway, DHT Holdings, Novo Nordisk
- Wall Street securities analysts revised their ratings and price targets on several
U.S.-listed companies, including Berkshire Hathaway, DHT Holdings and Novo Nordisk, on Monday.
HIGHLIGHTS
* Berkshire Hathaway Inc : KBW raises target price to $325,000 from $310,000
* CyrusOne Inc : Jefferies raises to buy from hold
* DHT Holdings Inc : Evercore ISI cuts to in line from outperform
* Frontline Ltd : Evercore ISI cuts to in line from outperform
* Novo Nordisk : Cowen and Company initiates with market perform, $72 target price
Following is a summary of research actions on U.S. companies reported by Reuters on Monday. Stock entries are in
alphabetical order.
* 2U Inc : Barrington Research raises price target to $30 from $25
* Abbvie Inc : Mizuho raises target price to $101 from $100
* Abbvie Inc : RBC raises price target to $98 from $93
* Abbvie Inc : SVB Leerink raises target price to $107 from $103
* Activision Blizzard Inc : Credit Suisse raises target price to $79 from $69
* Allegiance Bancshares Inc : KBW raises target price to $32 from $31
* Allscripts Healthcare Solutions Inc : Cowen and Company cuts PT to $8 from $15
* Alteryx Inc : Rosenblatt Securities cuts price target to $115 from $145
* Amarin Corporation Plc : SVB Leerink raises target price to $9 from $7
* Amazon.Com Inc : Independent Research raises PT to $2900 from $2400; rating buy
* American Airlines : Citigroup cuts price target to $9 from $10
* American Tower Corp : Citigroup cuts price target to $266 from $280
* American Tower Corp : RBC raises target price to $261 from $240
* Angi Homeservices Inc : SunTrust Robinson cuts target price to $10 from $14
* Antero Midstream Corp : Citigroup cuts to neutral from buy; cuts PT to $4 from $7
* Apollo Global Management Inc : BMO raises target price to $43 from $39
* Apollo Global Management Inc : Citigroup cuts price target to $55 from $61
* Apollo Global Management Inc : Credit Suisse cuts target price to $44 from $45
* Apollo Global Management Inc : Evercore ISI raises target price to $43 from $41
* Apollo Global Management Inc : Jefferies raises target price to $45 from $44
* Apollo Global Management Inc : KBW cuts target price to $47 from $49
* Apollo Investment Corp : SunTrust Robinson cuts target price to $12 from $19
* Ardmore Shipping Corp : Evercore ISI cuts target price to $10 from $11
* Ares Capital Corp : SunTrust Robinson cuts target price to $15 from $20
* Arthur J Gallagher & Co : KBW cuts target price to $97 from $100
* Asgn Inc : BMO raises target price to $66 from $51
* Avadel Pharmaceuticals Plc : Piper Sandler raises target price to $18 from $14
* Bain Capital Specialty Finance Inc : Credit Suisse cuts PT to $15.50 from $20.50
* Balchem Corp : H.C. Wainwright cuts price target to $104 from $116
* Bank of America Corp : UBS raises price target to $21 from $20
* Bank of N.T. Butterfield & Son Ltd : KBW raises target price to $28 from $24
* Bank of N.T. Butterfield & Son Ltd : Raymond James raises PT to $24 from $20
* Bank7 Corp : Piper Sandler raises target price to $12 from $11
* Barings BDC Inc : Compass Point raises to buy from neutral
* Barings BDC Inc : KBW cuts target price to $8 from $8.5
* Bcb Bancorp Inc : D.A. Davidson cuts target price to $10 from $11
* Berkshire Hathaway Inc : KBW raises target price to $325,000 from $310,000
* Berkshire Hathaway Inc : UBS cuts target price to $350000 from $358000
* Berry Global Group Inc : Citigroup raises price target to $47 from $42
* Beyond Meat Inc : Jefferies raises target price to $83 from $72
* Big Lots Inc : Talsey Advisory Group raises to outperform from market perform
* Big Lots Inc : Telsey Advisory Group raises price target to $31 from $20
* Biomarin Pharmaceutical Inc : Wedbush cuts target price to $145 from $164
* Black Diamond Therapeutics Inc : HC Wainwright initiates at rating buy and $53 PT
* Bloomin' Brands Inc : MKM Partners raises target price to $13 from $11
* Booking Holdings Inc : Credit Suisse cuts target price to $1,790 from $1,870
* Brigham Minerals Inc : SunTrust Robinson cuts target price to $16 from $19
* Brookline Bancorp Inc : KBW cuts target price to $11 from $12
* Brooks Automation Inc : Stephens raises target price to $40 from $37
* Brunswick Corp : BMO raises target price to $37 from $34
* Brunswick Corp : Keybanc raises target price to $52 from $47
* Builders Firstsource Inc : Barclays raises target price to $19 from $16
* Builders Firstsource Inc : Benchmark cuts target price to $22 from $32
* Builders Firstsource Inc : BTIG cuts target price to $23 from $31
* Builders Firstsource Inc : D.A. Davidson raises target price to $22 from $20
* Builders Firstsource Inc : Evercore ISI raises target price to $21 from $15
* Builders Firstsource Inc : RBC raises target price to $20 from $15
* Builders Firstsource Inc : Stifel raises price target to $21 from $18
* Builders Firstsource Inc : SunTrust Robinson raises target price to $20 from $17
* Builders Firstsource Inc : Wedbush raises target price to $23 from $19
* Cabot Oil & Gas Corp : Piper Sandler cuts target price to $21 from $22
* Cabot Oil & Gas Corp : Susquehanna raises target price to $24 from $23
* Caci International Inc : JP Morgan raises target price to $270 from $220
* Callon Petroleum Co : Tudor Pickering Holt cuts to sell from hold
* Camping World Holdings Inc : Jefferies cuts target price to $8 from $12
* Carlyle Group Inc : Citigroup cuts price target to $33 from $34
* Carter Bank and Trust : Raymond James cuts target price to $10 from $13
* Carter'S Inc : Monness Crespi Hardt cuts target price to $100 from $115
* Charter Communications Inc : Cowen and Company raises PT to $597 from $593
* Charter Communications Inc : JP Morgan raises target price to $575 from $550
* Charter Communications Inc : Keybanc raises target price to $604 from $576
* Charter Communications Inc : Rosenblatt Securities raises PT to $620 from $600
* Charter Communications Inc : TD Securities raises price target to $560 from $515
* Cheniere Energy Inc : Scotiabank raises target price to $68 from $67
* Cheniere Energy Partners LP : Scotiabank raises target price to $33 from $32
* Chevron Corp : Citigroup raises price target to $85 from $65
* Chevron Corp : Cowen and Company raises target price to $90 from $88
* Chevron Corp : Credit Suisse raises target price to $100 from $81
* Chevron Corp : Jefferies raises target price to $100 from $90
* Chevron Corp : JP Morgan raises target price to $103 from $97
* Choice Hotels International Inc : UBS cuts price target to $89 from $100
* Choice Hotels International Inc : UBS raises to buy from neutral
* Cigna Corp : Bernstein cuts to market-perform from outperform
* Cigna Corp : Raymond James raises target price to $240 from $210
* Citigroup Inc : UBS raises price target to $64 from $50
* Citizens Financial Group Inc : UBS raises price target to $26 from $18
* Citizens Financial Group Inc : UBS raises to buy from neutral
* Clorox Co : Citigroup raises price target to $206 from $182
* Clorox Co : Credit Suisse raises target price to $180 from $172
* Clorox Co : UBS raises price target to $168 from $155
* CNX Midstream Partners LP : Citigroup cuts price target to $8 from $17
* CNX Midstream Partners LP : Citigroup cuts to neutral from buy
* Coastal Financial Corp (Everett) : KBW raises target price to $16 from $15
* Cognex Corp : Berenberg raises target price to $60 from $52
* Cognizant Technology Solutions Corp : BMO cuts to market perform from outperform
* Cognizant Technology Solutions Corp : BMO raises target price to $59 from $58
* Colgate-Palmolive Co : Citigroup cuts price target to $75 from $78
* Colgate-Palmolive Co : Stifel raises price target to $75 from $72
* Columbia Banking System Inc : KBW cuts target price to $34 from $37
* Community Bankers Trust Corp : Stephens cuts target price to $7.50 from $9
* Community Health Systems Inc : Oppenheimer cuts target price to $7 from $8
* Concho Resources Inc : MKM Partners cuts price target by $5 to $75
* Concho Resources Inc : Simmons Energy raises target price to $59 from $54
* Concho Resources Inc : TD Securities raises price target to $53 from $49
* Conocophillips : MKM Partners raises target price by $1 to $58
* Consolidated Communications Holdings Inc : Citigroup raises PT to $6 from $5
* Consolidated Communications Holdings Inc : Guggenheim raises PT to $4 from $3.
- 05/04/2020
|
Allscripts Healthcare Solutions (NASDAQ:MDRX) Upgraded at ValuEngine
- Allscripts Healthcare Solutions (NASDAQ:MDRX) was upgraded by equities research analysts at ValuEngine from a “sell” rating to a “hold” rating in a note issued to investors on Friday, ValuEngine reports. A number of other brokerages have also weighed in on MDRX. Piper Sandler decreased their price objective on shares of Allscripts Healthcare Solutions from $12.00 […]
- 05/02/2020
|
Outlook on the Global Independent Software Vendors Market to 2027 - Industry Analysis, Size, Share, Growth, Trends, and Forecast - ResearchAndMarkets.com
- The "Independent Software Vendors Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027" report has been added to ResearchAndMarkets.com's offering.
- 05/01/2020
|
Medical Billing Outsourcing Industry Opportunity & Forecast, 2020-2025 - ResearchAndMarkets.com
- The "Medical Billing Outsourcing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering.
- 05/01/2020
|
Analysts Estimate AllScripts Healthcare (MDRX) to Report a Decline in Earnings: What to Look Out for
- AllScripts (MDRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 04/30/2020
|
Analysts Estimate AllScripts Healthcare (MDRX) to Report a Decline in Earnings: What to Look Out for
- AllScripts (MDRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 04/30/2020
|
E-Prescribing Market to Grow $4,152.7 Million at a CAGR of 21.4% by 2026
- The global e-prescribing is expected to grow at a CAGR of 21.4% from 2019 to 2026 and will surpass $4,152.7 million by 2026, claims a new research report published by Big Market Research. PORTLAND, Ore., April 30, 2020 (GLOBE NEWSWIRE) -- As per the report, the rising need to curtail escalating healthcare
- 04/30/2020
|
E-prescribing Market to Reach USD 4,017.79 Million by 2026, Attributed to Increasing Prevalence of Chronic Diseases Among World Population: Fortune Business Insights™
- Pune, April 30, 2020 -- The global E-prescribing market size is projected to reach USD 4,017.79 million by 2026 owing to the implementation of e-prescribing software in the.
- 04/30/2020
|
Allscripts' EPSi Releases Coronavirus Planning Analytics Tool
|
EPSi Releases Covid-19 Planning Analytics Tool
- EPSi, Allscripts’ (NASDAQ: MDRX) flagship budgeting, planning/forecasting, cost accounting and financial decision support platform, announced the release of its COVID-19 Planning Analytics tool. Initially, the tool will be made available to EPSi’s 1,000+ hospital clients at no cost. The COVID-19 Planning Analytics tool includes five independent analyses focused on answering the tough questions being asked by health system leaders across the country – When will we run out of ICU capacity? What is the financial burden of COVID and how does this change with duration? When can I resume elective procedures? How much do I need to reduce costs in my remaining budget to return to baseline?
- 04/30/2020
|
Outlook on the Worldwide Smart Hospital Industry to 2024 - Featuring Philips, GE Healthcare & Medtronic Among Others
- Dublin, April 30, 2020 -- The "Smart Hospital Market Report: Trends, Forecast and Competitive Analysis" report has been added to ResearchAndMarkets.com's offering..
- 04/30/2020
|
Global Patient Engagement Solutions Market 2020-2024: Increasing Adoption of Mobile Technology for Patient Engagement - ResearchAndMarkets.com
- The "Global Patient Engagement Solutions Market 2020-2024" report has been added to ResearchAndMarkets.com's offering.
- 04/30/2020
|
Allscripts Healthcare Solutions Target of Unusually Large Options Trading (NASDAQ:MDRX)
- Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) was the target of some unusual options trading on Wednesday. Investors bought 3,799 call options on the stock. This is an increase of approximately 1,451% compared to the typical volume of 245 call options. In other Allscripts Healthcare Solutions news, CAO Brian Farley sold 24,000 shares of the company’s stock […]
- 04/30/2020
|
Global E-Prescribing Market 2020-2026: Office-based Physicians Sector Set to Witness Strong Growth - ResearchAndMarkets.com
- The "E-Prescribing Market by Component, Deployment and End User: Global Opportunity Analysis and Industry Forecast, 2019-2026" report has been added to ResearchAndMarkets.com's offering.
- 04/30/2020
|
Analysts Estimate AllScripts Healthcare (MDRX) to Report a Decline in Earnings: What to Look Out for
|
Veradigm Dedicated to Helping Combat COVID-19
- As a leading provider of data and technology solutions, Allscripts (NASDAQ: MDRX) business unit, Veradigm, is at the forefront of the fight to help providers and researchers, and the patients they serve. The company is committed to leveraging its technology to help providers identify patients at risk for the virus and ensure they have the information and tools needed to help them. In addition, Veradigm is a founding member of a consortium dedicated to providing the data necessary for advancing COVID research.
- 04/29/2020
|
Vecna Technologies Touchless Mobile Check-in Reduces Contact Amid COVID-19 Crisis
- Vecna Technologies, a leading provider of healthcare information technologies focused on patient solutions and infection surveillance, is helping reduce staff and patient contact amid the COVID-19 crisis with its Vecna Touchless Mobile Patient Check-in software.
- 04/29/2020
|
